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INTRODUCTION 
 Malaria is the disease of antiquity, having been recognized since 
Vedic times in India 1&2. It is distributed worldwide with a great 
socioeconomic impact on the countries with intense transmission 
particularly in tropical regions 3. Now malaria is a reemerging disease and 
is of major public health concern 4.  
 Patients affected with malaria present with varied clinical picture 
from simple fever and malaise to life threatening symptoms like cerebral 
malaria. Thus malaria should be considered in the differential diagnosis 
of any febrile illness especially in those with a history of travel to malaria 
endemic places 5.   
Diagnosing the disease only with clinical features lead to         
over-diagnosis especially in endemic areas. Thus parasite based diagnosis 
is recommended for all patients by WHO 6. It urges malaria endemic 
countries to diagnose the disease by laboratory testing. It also emphasizes 
on early diagnosis, appropriate anti-malarial treatment and effective 
surveillance.  
A sensitive diagnostic tool is essential to ensure appropriate 
treatment for the patients. Thus, there is a need to review the currently 
available diagnostic methods in terms of feasibility in hospitals, rapidity 
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in diagnosis, cost of the test and its usefulness to patient, laboratory and 
physician caring the patient.  
 Common diagnostic procedure followed at Coimbatore Medical 
College Hospital, Coimbatore is thick and thin smear preparation and 
staining with Leishman’s stain. Though it allows detection, quantification 
and identification of Plasmodium species, has limited sensitivity when 
parasitemia is low and in detecting mixed infection.  
 Thus emphasis has been placed on alternative methods in the 
diagnosis of malaria. Some of them are Quantitative Buffy Coat, 
fluorescent microscopy, confocal microscopy, immunochromatography, 
ELISA, Polymerase Chain Reaction, automated hematology analyzers 
and microarray. 
In this study, Rapid Diagnostic Tests, ELISA for antigen detection 
and PCR are compared with the Gold standard test ‘Microscopy’, so that 
these tests can be used as an alternative in the diagnosis of malaria. 
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AIMS AND OBJECTIVES 
Overall Aim: To find alternatives to Conventional Microscopy in the 
Laboratory diagnosis of Malaria. 
Specific Objectives: 
1. To identify malarial parasite in patients with low parasite densities. 
2. To compare the sensitivity and specificity of Rapid Diagnostic    
Test (RDT) with conventional microscopy. 
3. To evaluate the diagnostic performance of panLDH Antigen 
detection ELISA.  
4. To evaluate the role of PCR in the diagnosis of malaria. 
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REVIEW OF LITERATURE 
History: 
• Malaria has had an enormous impact on human health for 
millennia. Hippocrates described the clinical presentation           
and complications of malaria in the fifth century BC.               
Nearly half a millennium later, Celsus described the        
distinctions between the clinical manifestations of disease caused 
by Plasmodium falciparum, Plasmodium vivax and             
Plasmodium malariae. 
• In 1630s, it was discovered that the bark of the cinchona tree from 
Peru could treat the disease. It was imported to Europe and was 
widely used in treatment.  Morton and Sydenham in England and 
Torti in Italy distinguished between fevers that responded to the 
bark and those that did not. In England, the responsive fevers were 
called “agues”. In the eighteenth century, they received the Italian 
name, Malaria (mal aria – bad air), because it was believed that the 
disease was transmitted through the foul air of swampy areas.  
• In 1820, Pelletier and Caventou determined the structure of quinine 
and the era of modern chemotherapy was initiated. 
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• In 1880 Laveran, a French military physician working in Algeria, 
made the first description of malaria parasites in the blood of 
patient and was awarded noble prize in 1907. 
• In 1883 Marchiafava, used Methylene blue for staining malarial 
parasites 
• In 1887 Ronald Ross, a British military physician working in India 
discovered the transmission of malaria by Anopheles mosquitoes.  
• In 1891 Romanowsky introduced polychrome methylene blue for 
staining malaria parasites. 
• In 1898 Ronald Ross, demonstrated oocyst of Plasmodia on the 
stomach wall of an anopheline mosquito and later demonstrated 
lifecycle of malarial parasite in mosquito. He was awarded noble 
prize in 1902. 
• In 1898-1899, Italian scientists Bignami, Bastianelli and Grassi, 
elucidated the life cycle in humans. This led to initiation of control 
efforts. 
• In 1976, Trager and Jensen successfully cultivated and 
maintained Plasmodium falciparum in vitro, in human red blood 
cells 7. 
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Currently the impact of malaria in many parts of the world is 
similar to or greater than it was 50 years ago as the campaign of 1950s 
and 1960s to eradicate malaria came to a halt 8. 
On June 13, 2007, the U.S. Food and Drug Administration (FDA) 
approved the first Rapid Diagnostic Test (RDT) for use in the United 
States 9. 
Serological and molecular diagnostic procedures for detection of 
the malarial enzymes and nucleic acid respectively have come into 
existence.  
Epidemiology:  
Malaria is an overwhelming problem in developing countries 
especially in the Tropical region 10. As per the World Malaria Report 
2011, malaria is currently endemic over 106 countries. Globally, around 
216 million cases of malaria were reported in 2010, leading to 
approximately 655,000 deaths. Out of this, 81% percent of cases and 91% 
of deaths occurred in the African region. Mortality was more in children 
under 5 years of age accounting for about 86% of the total 11. 
 In India, the annual incidence of malaria is 1.5 million cases 12. Of 
this, about 88% of malaria cases and 97% of deaths are reported from 
North-eastern states.  However other states are also vulnerable with local 
and focal outbreaks of malaria 13. 
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 In TamilNadu, total no. of malaria cases estimated during the year 
2008 to 2009 was 3678 14.          
Geographical distribution: 
The global distribution and prevalence of malaria have not changed 
appreciably for the past few decades. It is found in tropical regions of 
sub-Saharan Africa, many areas of Indian subcontinent, Southeast Asia, 
Central and South America 8.  
Malaria continues to be a major public health threat in India 
particularly due to Plasmodium falciparum. Orissa, Chattisgarh,        
West Bengal, Jharkhand and Karnataka are the most affected states in 
India 12. 
Out of the total malaria cases in Tamilnadu, 74% are reported in 
Chennai City and another 8.4% in Tuticorin, Erode, Vellore, Dindigul, 
Salem, Tiruchengode, Tiruvallur and Tiruvottriyur 15. 
There is difference in the distribution of the vectors of malaria and 
also prevalence of Plasmodium species in different parts of the world.  
Vectors:  
Anopheles culicifacies is the main vector of rural and peri-urban 
areas and is widespread in India. It is found in natural and man-made 
breeding sites. Anopheles stephensi is responsible for malaria in urban 
and industrial areas (Fig a). Anopheles fluviatilis is the main vector in 
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hilly areas and forests. Anopheles minimus is the vector in foothills. 
Anopheles dirus is the vector in the forest of north-east. Anopheles 
epiroticus in Andaman and Nicobar islands 13. Anopheles stephensi is the 
commonest species in Coimbatore. 
Plasmodium species: 
• Plasmodium falciparum is mostly confined to tropical 
climates and is the major cause of malaria in tropical regions 
of Africa, north-eastern regions of India and Sri Lanka. 
• Plasmodium vivax occurs in temperate zones as well as in 
subtropical areas. It is the wide spread species found in 
India. 
• Plasmodium ovale is prevalent in West Africa.  
• Plasmodium malariae has a limited distribution in India.  
• Plasmodium knowlesi, the most recently described 
“zoonotic” species, is restricted to South-East Asia 3,7.  
There is increase in malarial cases in non-endemic areas. This is 
due to immigration, tourism and professional travelling of people from 
malaria endemic areas 10,16,17. In the year 2000, a total of 145 cases were 
imported to Tamil Nadu from Kerala, 121 from Andhra Pradesh and 99 
cases from Karnataka 15. 
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Malaria - an overview of the parasite and the disease: Malaria is 
caused by Plasmodium, which is transmitted through the bites of infected 
female anopheles mosquitoes. Five species have shown to infect humans: 
Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, 
Plasmodium malariae and Plasmodium knowlesi 3&7. 
Plasmodium undergoes sexual cycle in the mosquito and an 
asexual cycle in man. During the bite of an infected mosquito, 
Plasmodium sporozoites are injected into the blood which moves to liver 
cells where they develop into liver schizonts. After the rupture of 
schizonts, thousands of merozoites are released into the bloodstream. 
Each merozoite invades a red blood cell (RBC). In the RBC, they develop 
into trophozoites, mature into schizonts. This inturn divide into new 
merozoites which invade new RBCs. After one or two weeks, 
gametocytes are produced. These continue the sexual cycle when taken 
up by a mosquito during the next blood meal. Liver schizonts of 
Plasmodium vivax and Plasmodium ovale may persist for months in the 
liver before releasing merozoites into the blood. The persistent 
(“dormant”) forms are called hypnozoites which cause delayed symptoms 
resulting in relapse 3&7. 
Children, pregnant women, immunosuppressed individuals and 
non-exposed travellers are particularly vulnerable to malaria 10. 
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Malaria is also transmitted through blood transfusion and 
transplacental transmission. 
Malaria is characterized by fever with or without periodicity, chills, 
excessive sweating, malaise, headache, myalgia, arthralgia, anorexia, 
nausea and vomiting. The symptoms of malaria can be non-specific and 
mimic illness caused by many viral and bacterial pathogens 8. If not 
treated, malaria can become life-threatening. This is especially the case 
for Plasmodium falciparum which unlike Plasmodium vivax,  
Plasmodium ovale and Plasmodium malariae can infect RBCs of all ages 
and cause elevated parasite densities. In addition, infected RBCs of 
Plasmodium falciparum stick to the vascular endothelium of the blood 
vessels in internal organs (sequestration as in the figure b), leading to 
obstruction in blood flow, resulting in lethal complications such as 
cerebral malaria, pulmonary oedema and impairment of liver and renal 
functions 8&18. Prompt diagnosis is essential for the treatment and 
outcome of Plasmodium falciparum. 
  Plasmodium vivax accounts for almost half of the malaria 
infections worldwide and is no longer considered as a mild infection. 
Complicated infections with Plasmodium vivax have been demonstrated 
both in endemic countries and among travellers of non-endemic countries 
on their return from endemic countries 19.
  
Fig a: Female Anopheles stephensi taking a blood meal 
 
Fig b: Sequestration of RBCs in the blood vessels of internal 
organs 
 
 
CD – Cluster of Differentiation, CS - Chondroitin Sulphate A, CR - Complement Receptor, 
HS - Heparan sulphate, E-selectin – Endothelium selectin, ICAM– Intracellular Adhesion 
Molecule, TSP - Thrombospondin, VCAM – Vascular Cell Adhesion Molecule.
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Emerging threats: 
• Plasmodium falciparum resistance to artemisinins was first 
confirmed on the Cambodia-Thailand border in 2009. It has now 
been identified in Myanmar and Vietnam. WHO has recommended 
all the countries to ban the marketing of oral artemisinin-based 
monotherapies, which is one of the major factors fostering the 
emergence and spread of resistance 20.  
• The problem of insecticide resistant mosquitoes is increasing. Four 
classes of insecticides are organo-chlorine compounds like DDT, 
organo-phosphorus insecticides like malathion, parathion, abate, 
carbamates like carbaryl, propoxur and synthetic pyrethroids like 
resmethrin.  According to the World malaria report 2011, 45 
countries around the world have identified resistance to at least one 
of the four classes of insecticides used for malaria vector control. 
India and malaria-endemic countries in Sub-Saharan Africa are one 
among them 20.  
 With the emergence of insecticide resistance in vectors, the 
National Malaria Eradication Programme came to a standstill. There was 
resurgence of malaria in early 1970, following which many programmes 
like National antimalarial programme, National Vector Borne Disease 
Control Programme, Introduction of RDT programme, Artemesinin 
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Combination Therapy (ACT), Introduction of Long Lasting Insecticide 
Nets to control malaria came into existence 13. 
Diagnosis of malaria: 
 Malaria is diagnosed by clinical, parasitological, immunological 
and molecular methods. Malaria can mimic many diseases. The golden 
rule is to always include malaria as one of the differential diagnosis of a 
febrile illness without any focus of infection. 
In the pre-eradication era (prior to National Malaria Eradication 
Programme, 1958), spleen rate, average enlarged spleen, were used to 
measure the endemicity of malaria in the community. These were found 
nonspecific in tropical countries because splenomegaly is also seen in 
many cases other than malaria 13. 
Intensive research on various diagnostic tools of malaria has 
resulted in improved diagnostic procedures. The aim of these procedures 
is to provide simple and rapid non-microscopic diagnostic methods with 
increased sensitivity for detecting the parasite.  
Purpose of an appropriate diagnostic method is to rule out malaria in 
symptomatic patients, to guide the physician in starting an appropriate 
treatment and to help in epidemiological studies. 
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Diagnostic methods: 
1. Microscopy:   
i. Staining of Thick and thin blood films with Romanowsky’s 
stains followed by examination under light microscope.   
ii. Fluorescent microscopy or a microscope with an interference 
filter system (Kawamato method) - used to examine 
quantitative buffy coat and acridine orange stained smears. 
iii. Confocal microscopy – A microscope system which removes 
out-of focus information optically. It provides better 
resolution image with high contrast and reduced glare. 3-D 
reconstruction is also possible with this microscopy 21. It 
helps to visualize live intra-erythrocytic malarial parasite, to 
quantify malarial pigments and to find out the antimalarial 
drug resistance. 
2. Quantitative Buffy Coat (QBC) :   
Here the blood is centrifuged in a specially designed microcapillary 
tube fitted with a plastic float. The tube is precoated with fluorescent dye. 
The float spreads the buffy coat against the edge of the tube. Parasite and 
the leucocytes take up the dye, which is fluorescent when examined under 
ultraviolet light in a fluorescent microscopy. QBC is slightly more 
sensitive than thick films but has some limitations: species identification 
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and quantification are difficult. It requires microcapillary tubes and 
fluorescent microscopy, which are expensive. QBC cannot be stored for 
later reference 3&22. 
3. Immunological methods: 
Immunological methods detect parasite antigens or the host antibodies 
directed against the parasite. The detection of antigens is an acceptable 
alternative to parasite detection. The detection of antibodies is of limited 
use for individual diagnosis as they cannot distinguish between current 
and past infection. 
A good antigen detection test should detect only the current infection. 
It should not produce any false negatives for it to be highly sensitive. It 
should produce fewer false positives for it to be highly specific 3. 
ELISA, Radioimmunoassay, immunochromatography are some of the 
methods to detect malarial antigens 3. 
4. Molecular methods: 
The application of molecular methods to diagnose malaria has several 
advantages over traditional methods. It serves as a research tool to 
monitor malaria control programs and to perform quality control checks 
on microscopic diagnosis. It helps to determine the distribution of 
important genes such as genes associated with drug resistance. 
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 Sensitivity of nucleic acid probes has increased exponentially with 
the availability of amplification methods such as Polymerase chain 
reaction. 
5. Newer advances in the diagnosis of malaria: 
i. Microarrays: Microarrays are collection of nucleic acid sequences 
immobilized onto a solid support (slide). The basis of Microarray is 
classical Northern blotting – base pairing and hybridization between 
nucleic acids. Each unique sequence form a tiny feature, called a ‘spot’ 
or ‘target’.  Target in the sample is labelled with fluorescent dyes. 
Following hybridization, the slide is scanned with the help of LASER 
scanner to generate images. The image is then analyzed with the help 
of microarray image analysis software. 
Microarray differs from northern blotting in detecting thousands of   
genes simultaneously. It helps in detecting different stages of intra-
erythrocytic development and drug resistance 23. 
ii. Automated parasite detection system(APDS): 
Automated Giemsa staining apparatus creates a thin smear, fixes the 
cells with methanol, stains with Giemsa stain, rinses and dries the 
slide and inspects the slide under microscope. The data is acquired in 
the computer. Computer algorithm determines the presence or absence 
of malaria 23 (Fig c).  
  
Fig c: Automated Parasite Detection System
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Advantages of APDS are low false-positive & false-negative 
rates. It can diagnose malaria within 60 minutes. It is a portable 
device, thus easy to transport. It will serve as a low-cost, easily 
accessible malaria testing device in remote areas, thus decreasing 
mortality rates. 
iii. Malaria detection by haematology analysers, as a method of 
malaria parasite detection came into reality only after the 1990s. 
But false positivity and high cost limit their use 23. 
iv. Automated Microscopy Diagnosis (Computer Vision For 
Microscopy): 
• Underlying principle: Ability to differentiate between non-parasitic 
stained components/bodies (RBC’s, WBC’s, platelets, artefacts) 
and the malaria parasite using visual information (Visual Basic 
Computer language). 
• It requires combination of microscopy, digital photography, and 
computer software. 
• Its most common application is in the diagnosis of malaria 23. 
v. Automated nucleic acid extraction:  
Fully automated DNA extraction techniques are now available 
which helps to process a large number of samples 23. This is of 
great help in RT-PCR. 
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In this study, the diagnostic tools reviewed and performed were 
peripheral smear and microscopy, rapid diagnostic tests, ELISA and Real 
time PCR. 
Blood smears: 
  Conventional Microscopic examination of peripheral smear is 
accepted as the universal “gold standard” for the diagnosis of         
malaria 7&22.  Both thick and thin smears are prepared from the capillary 
blood or anticoagulated venous blood. They are stained with one of the 
Romanowsky’s stains such as Leishman’s stain, Jaswantsingh 
bhattacharji stain, Giemsa, Wright’s, or Field’s stain 18. Different stages 
of the parasite like ring forms, schizonts and gametocytes can be 
visualized 18.  
Microscopic examination of the blood smear can detect the 
parasites, quantitate parasitemia and demonstrate malarial pigments.  
Thick smear:  
 During the preparation of thick smear, concentrated red blood cells 
are lysed with distilled water. Smear is dried thoroughly and stained 
without fixing 7.  
   Its thickness should be such that it contains 10 layers of RBCs. 
Approximately 10 to 12 WBCs should be visible per oil immersion 
field24. Threshold of detection of malarial parasite in thick film is 5 to 20 
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parasites/µl of blood. At least 100 to 200 fields, each containing 20 
WBCs should be examined before a thick smear is reported as negative 
for malaria 7. 
Advantages of thick smear are - it allows examination of greater 
volume of blood. As the parasites are concentrated, it detects low levels 
of parasitemia especially during recrudescence or relapse 22&25. It is 30 
times more sensitive than thin smear 7. 
Disadvantages are – it does not help in speciation as the parasites in 
the lysed cells are distorted. So laboratories with limited experience may 
prefer thin smear 22&25. 
Thin smear: 
The thin smear consists of a single layer of RBCs. Thin smears are 
air-dried, rapidly fixed in alcohol and stained (alcohol fixation not needed 
for Leishman’s stain). The RBCs in the tail end of the smear are 
examined for the parasite. Threshold for detection of parasites with thin 
film is 100 parasites/µl of blood. 
 Thin smear helps to speciate, identify the stage of the parasite and 
to assess the response to treatment especially in areas where drug 
resistant falciparum is suspected.  
The disadvantage with thin smear is that it is less sensitive than a 
thick film when there is low parasitemia. 
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Advantages of microscopy are it is Simple and cheap. It can 
identify the presence of parasites, the infecting species, stage of the 
parasite and assess the parasite density.  
Limitations of microscopy are:  labour intensive, time consuming, require 
expertise and trained healthcare workers. It is not suitable for 
examination of large number of blood smears. The sensitivity of detecting 
the parasite decreases with low parasitemia particularly in falciparum 
malaria where sequestration of the parasites occurs in the capillaries of 
the internal organs and in mixed malarial infection 26. 
 An expert microscopist detects the parasite even when its level in the 
blood is around 5 parasites/µl of blood.  But, an average microscopist 
detects the parasite only when the level of the parasite is around            
50-100/µl of blood. This has probably resulted in underestimation of 
malaria infection rates, especially in cases with low parasitemia and 
asymptomatic malaria 27. 
Intradermal smears: 
 Smears prepared from intradermal blood have been shown to contain 
more mature forms of Plasmodium falciparum than peripheral blood 1. 
Rapid diagnostic tests: 
Immunochromatography tests are based on the capture of the 
parasitic antigens from the peripheral blood using either monoclonal or 
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polyclonal antibodies. Currently, immunochromatography tests target   
the Histidine-Rich Protein 2 (HRP2) of Plasmodium falciparum, a pan-
malarial Plasmodium aldolase, and the parasite specific or pan-malarial 
Lactate Dehydrogenase (pLDH).  In India, NVBDCP emphasize on use 
of RDT in the diagnosis of malaria especially Plasmodium falciparum 
malaria to improve diagnostic efficiency in Peripheral Health Centres 28. 
Histidine-Rich Protein (HRP): 
 Plasmodium falciparum infected RBCs synthesize three Histidine-
rich proteins namely HRP-1, HRP-2 and HRP-3. HRP-1 was identified in 
all knob-positive Plasmodium falciparum but only small amounts were 
present in culture-adapted strains. HRP-2 was identified in all 
Plasmodium falciparum parasites regardless of the knob phenotype and 
recovered from culture supernatants as a secreted water soluble protein. 
HRP-3 was present at the lowest concentration when compared to HRP-1 
and HRP-2. Neither HRP-1 nor HRP-2 was found in non-falciparum 
malaria 25. 
Histidine-rich protein 2 of Plasmodium falciparum (PfHRP2) is a 
water soluble protein produced by asexual stages and young gametocytes 
of Plasmodium falciparum, expressed on the internal surface of the red 
cell membrane and also secreted into the blood 3. It remains in the blood 
for at least 28 days after the initiation of antimalarial therapy 1&25.  
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 Several RDTs targeting PfHRP2 have been developed which are 
highly sensitive but false negatives have been reported in patients whose 
parasites have a rare antigenically variant form of PfHRP2 1.  
Plasmodium specific Lactate Dehydrogenase: 
Plasmodium is a homolactate fermenter. It depends extensively 
upon anaerobic glucose metabolism for ATP production. Parasite LDH is 
a 316 amino acid soluble glycolytic enzyme produced by the asexual and 
sexual stages of the live parasites and released from the infected 
erythrocytes. It converts pyruvate to lactate while regenerating NAD+ for 
continued use in glycolysis. pLDH has notable structural and kinetic 
properties making it different from mammalian and bacterial LDH 
enzymes 29. Parasites should be viable for pLDH to be detected. pLDH 
with different isomers exist for each species 22&30. 
 With pLDH as the target, quantitative immunocapture assay, 
qualitative ELISA, qualitative immunochromatographic card tests using 
monoclonal/polyclonal antibodies,  immunodot assays, and  dipstick 
assays using polyclonal antibodies have been developed.  
pLDH is superior to HRP-2 for its shorter shelf life in blood. pLDH 
clears at about the same time as the parasites, following successful 
treatment, thus useful for monitoring responses to drug therapy and 
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detecting drug-resistant malaria because the level of pLDH correlates 
with the number of viable malarial parasites in the blood. 
Plasmodium specific aldolase: 
Plasmodium aldolase is an enzyme of the parasite              
glycolytic pathway expressed by the erythrocytic stages of                        
Plasmodium falciparum as well as the non-falciparum malarial   parasites 
in the blood. Monoclonal antibodies against Plasmodium aldolase are      
pan-specific in their reaction and have been used in the combined 'P.f/P.v' 
immunochromatographic test that targets the pan malarial               
antigen (PMA) along with PfHRP2. 
The RDTs have been developed in different test formats like the 
dipstick, strip, card, cassette and the latter has provided a more 
satisfactory device for safety and it is user friendly. The test procedure 
varies between the test kits. In general, the blood specimen: finger-prick 
blood specimen or anticoagulated blood or plasma is added to the sample 
well and lysing/washing buffer is added. Labelled antibody is pre-
deposited in the cassette during manufacture. If the target antigen is 
present in the blood, a labelled antigen-antibody complex is formed and it 
migrates up the test strip to be captured by the pre-deposited capture 
antibodies specific against the antigens and against the labelled antibody 
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(as a procedural control). Coloured lines are formed by the immobilized 
antigen-antibody complexes.  
Immuno-enzymatic tests are of immense help in patients with 
clinical suspicion of severe falciparum malaria and in detecting mixed 
Plasmodium falciparum and Plasmodium vivax infections where parasites 
(Plasmodium falciparum) are not detected microscopically because the 
parasites are sequestered in the blood vessels of internal organs 1&26.  
RDTs are rapid, simple to perform and easy to interpret 31. One test 
can be completed in 10-15 minutes and many can be done 
simultaneously. They are highly sensitive and specific. It does not require 
expertise, equipment, or laboratory facilities. Unskilled staff with only a 
little training can perform the test and hence most suitable for field 
conditions 32. 
Thus it is possible to detect malarial parasites even in peripheral 
settings where there is a lack of basic equipments and infrastructure. 
These rapid tests can be performed and interpreted by primary health care 
workers. This in turn helps in early and appropriate management of 
malaria in Low level health care facilities 33&34.  
 There exist certain limitations for RDT. The sensitivity of RDT to 
detect malarial parasite is good at parasite densities >500/µl of blood   
but, sensitivity decreases as the parasitic density decreases below this 35.  
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It cannot quantify the parasite density or differentiate sexual and asexual 
stages of the parasite. It is of relatively high cost. False positivity due to 
persistence of PfHRP2 and cross reactivity with rheumatoid factor can 
occur.  
Reasons for persistent PfHRP2:  
1. Persistent viable asexual stage parasitemia below the detection 
limit of microscopy 
2. Delayed clearance of circulating antigen and 
3. Persistent sexual stage forms following treatment 36,37. 
ELISA for antigen detection: 
 The malarial antigens pLDH can also be detected by Enzyme 
linked immunosorbent assay.  
Principle: 
 The pLDH antigen in the sample is detected by direct sandwich 
ELISA. Here the antigen in the sample binds to the monoclonal antibody 
coated in the microtitre well. When a second monoclonal antibody 
linked to biotin is added, it binds to immobilized antigen. The addition of 
streptavidin-HRP conjugate results in binding of the conjugate to biotin. 
When substrate is added, the HRP enzyme cleaves the substrate and 
results in formation of coloured product. The rate of colour formation is 
directly proportional to the amount of antigen in the sample. 
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Advantages of ELISA are simple to perform, large number of samples 
can be tested in a single test run within a short time frame and it is 
quantifiable 38. 
A disadvantage in using pan-specific LDH antibodies coated 
microwell for detecting malaria is - speciation cannot be done.  
Polymerase Chain Reaction: 
 Molecular methods based on DNA amplification have been applied 
to malaria diagnosis since the late 1980s 39. PCR showed high sensitivity 
by detecting ≤ 5 parasites / µl 25. PCR is also highly specific and detects 
drug resistance in Plasmodium falciparum 25. Conventional PCR is being 
widely used. With conventional PCR, carry over contamination during 
the manipulation of postamplication products can occur 40. 
 Real-time PCR methods are a recent development of the PCR 
methodologies. This new technique is based on fluorescence. Real-time 
PCR assays have closed amplification vessels for thermo-cycling, 
amplicon monitoring and detection. Amplicon (amplified target) is 
monitored as it gets generated. Monitoring of the amplified target is made 
possible by labelling of oligonucleotide probes with molecules capable of 
fluorescing. This decreases the need for excessive handling of samples, 
particularly the post-PCR handling of samples to detect the amplicons. 
These features significantly reduce the sample contamination. The 
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internal control provided in the kit helps to monitor the quality of DNA 
extraction and the PCR run, thus helps the user to monitor for PCR 
inhibition 41.  
  RT-PCR has the ability to detect multiple targets. This is made 
possible by using different probes labelled with specific fluorescent dye 
each having their own unique emission spectra 42.Thus multiple species 
can be identified in one run. This reduces carry over contamination and 
less time consuming.   
Genes targeted for species level differentiation of Plasmodium         
are the circumsporozoite genes and the 18SrRNA genes. 
PCR can also detect infection due to Plasmodium knowlesi, the newly 
discovered fifth species of Plasmodium responsible for human disease 27. 
PCR can identify, speciate, quantify the malarial parasites.  PCR can 
detect malaria even in asymptomatic subjects with submicroscopic 
parasite densities, who are the source of transmission and hindrance to 
elimination of malaria 43,44. It plays an important role in detecting drug 
resistant parasites 39.   
Advantages of RT-PCR: 
1. Reduced risk of contamination when compared to conventional 
methods. 
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2. Able to arrive at the result within 3 hours (including DNA 
extraction) 39. 
3. Automated PCR can process large number of samples. 
Limitations are it involves complex methodologies, costlier, needs 
specially trained technicians 27. It is not suitable for diagnosis of malaria 
in rural areas 45. 
Thus understanding the characteristics of malarial parasites, use of 
appropriate diagnostic procedures and a complete understanding of the 
limitations of each procedure is very important to choose an alternative 
diagnostic tool in the laboratory diagnosis of malaria. 
Early diagnosis helps in initiation of timely and appropriate treatment. 
This inturn prevents progression of uncomplicated malaria to severe 
disease, prevent death, interrupt transmission and minimize the spread of 
drug resistant parasite. 
Treatment: 
Treatment of malaria is primarily based on specific antimalarial 
chemotherapy and supportive therapy. 
Antimalarial drug should aim at:  
• Effective clinical cure by destroying all asexual forms of the 
parasite in the blood. 
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• Preventing relapse by destroying hypnozoites and extra-
erythrocytic forms. 
• Preventing transmission of infection to mosquitoes by destroying 
gametocytes. 
Commonly followed regimen in India according to National Vector 
Borne Disease Control Programme is Chloroquine and Primaquine         
for Plasmodium vivax, Artemesinin Combination Therapy for 
Plasmodium falciparum. 
Prevention and control: 
 The preventive measures to control malaria mainly depend on 
treatment of infected individuals and reducing the transmission of 
malaria. 
The control measures include: 
1. Control of mosquito population 
2. Prevention of mosquito bites 
3. Chemoprophylaxis 
4. Vaccines 
Control of mosquito population: 
Adult mosquitoes are controlled by spraying residual insecticides 
such as Abate. The breeding of mosquito larvae is prevented by 
eliminating breeding places like swamps, flooding and flushing of 
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breeding places, spraying the breeding sites with oils and Paris green13. 
Larvicidal fishes like Gambusia feed on mosquito larvae. Bacillus 
thuringiensis var israelensis H14 produces toxins which kills the larvae. 
Thus they are used as biological control. 
Newer techniques like sterile insect technique which makes the 
male mosquitoes sterile and transgenic techniques which result in 
embryonic lethality are under field trial to control vector population 46. 
Prevention of mosquito bites: 
Mosquito nets, protective clothing, mosquito repellants and Long 
Lasting Insecticide Lined Nets (LLILN) help prevent mosquito bite 7&13. 
Chemoprophylaxis: 
 Chemoprophylaxis is recommended for travellers, migrant 
labourers and military personnel visiting endemic areas. The drugs 
commonly used are Chloroquine, Primaquine, proguanil, amodiaquine, 
mefloquine and fancidar in weekly doses for long term prophylaxis and 
doxycycline once daily doses for short term prophylaxis. 
The following is the chemoprophylaxis recommended by 
NVBDCP, Delhi. 
Short-term chemoprophylaxis (less than 6 weeks): 
Doxycycline: 100 mg once a day for adults and 1.5 mg/kg body weight 
for children more than 8 years old. The drug should be started 2 days 
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before travel and continued for 4 weeks after leaving the malaria   
endemic area. 
Long-term chemoprophylaxis (more than 6 weeks): 
Mefloquine: 5 mg/kg body weight (up to 250 mg) weekly and should be 
administered two weeks before, during and four weeks after leaving the 
malaria endemic area. 
Note: Doxycycline is contraindicated in pregnant and lactating women 
and children less than 8 years. Mefloquine is contraindicated in cases 
with history of convulsions, neuropsychiatric problems and cardiac 
conditions 12. 
Vaccines: 
 Most of the malarial vaccines developed are against Plasmodium 
falciparum, as it causes majority of deaths. Based on the stage against 
which the vaccines are directed, there are 4 types of malarial vaccines. 
They are Pre-erythrocytic vaccine candidates, Blood-stage vaccine 
candidates (Asexual stage), Transmission-blocking vaccine candidates 
(Sexual stage) and Multi stage vaccines. All the vaccines are under trial. 
The vaccine currently in phase III trial is RTS,S. It is a pre-
erythrocytic vaccine against Plasmodium falciparum, which inhibits the 
entry of parasite into the liver cells 47. It is a hybrid molecule expressed in 
Saccharomyces cerevisiae.  
31 
 
The vaccine RTS,S consist of : 
• Tandem repeat tetrapeptide (R) 
• C-terminal T-cell epitope containing (T) regions of CSP 
• Hepatitis B surface antigen (S) and  
• Unfused S antigen (S). 
• ASO1: Liposomal formulation as adjuvant. 
It induces both humoral and cell mediated immunity against the      
parasite 46. 
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MATERIALS AND METHODS 
This study “A review of alternatives to Conventional Microscopy 
in the Laboratory diagnosis of Malaria’’ is a cross-sectional study 
conducted in the Department of Microbiology at Coimbatore Medical 
College Hospital, Coimbatore from September 2011 to September 2012. 
 This study was undertaken after the acceptance of the proposal by 
Ethics committee. The study group included patients of all age groups 
and both sexes who were clinically suspected to have malarial fever (both 
inpatients and outpatients). 
No. of patients studied: 242. 
 Informed consent was obtained from all the patients enrolled in the 
study. Blood samples from these 242 patients were collected in a 
vacutainer with EDTA anticoagulant. Leishman’s staining of the 
peripheral smear, Rapid diagnostic test, ELISA for parasite specific pan 
malarial antigen (LDH) detection were done on all the samples. PCR was 
done for a total of 40 samples (20 microscopy positive and 20 microscopy 
negative samples).  
Collection, Transport and storage of blood samples: 
 Under strict aseptic precautions, 3ml of peripheral venous blood 
was collected in a vacutainer with EDTA from patients clinically 
suspected to have malaria before administration of antimalarial drugs. 
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 The blood samples thus collected were transported to the 
laboratory immediately. 
 Thick and thin smears were prepared and stained with Leishman’s 
stain. Immunochromatography test was performed. Remaining blood was 
aliquot for ELISA and PCR. Blood aliquot for ELISA were stored at       
4 - 8 0 C and test performed within 24 hours of sample collection. PCR 
was performed on 20 randomly selected Peripheral smear positive 
samples and 20 Peripheral smear negative samples. The selection of 
peripheral smear negative sample was based on the clinical history of the 
patient which should be suggestive of malaria and other investigations for 
identifying the cause of fever should be normal. Plasma was separated 
from the blood aliquot for PCR and RT-PCR was performed.   
Peripheral smear:  Thick and thin blood smears were prepared from 
venous blood on a clean, dry, grease free glass slide. 
Staining of thin smear with Leishman’s stain: 
Procedure: 
The air dried thin smear was covered with Leishman’s stain and 
allowed to stand for one minute. The stain was then diluted with twice its 
volume of distilled water. The diluted stain was allowed to remain on the 
slide for 10 minutes. The slide was held under an open tap and the stain 
flushed with gentle flow of water. The reverse side of the slide cleaned 
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with a wet and squeezed cotton wool. The slide was kept in an upright 
position to drain and dry. The stained and dried film was examined with 
oil-immersion objective of light microscope. 
Staining of thick smear: 
 The thick smear dehemoglobinised with distilled water, stained 
with Leishman’s stain as for thin smear and examined under oil-
immersion objective of light microscope. 
Rapid diagnostic test:  
Procedure: All the kit components were brought to room temperature 
prior to testing. The test device was taken out of the foil pouch and placed 
on a flat, dry surface. The circular end of a disposable specimen loop 
(capacity 5µl) provided in the kit was dipped into the blood and carefully 
placed into the round sample well. Four drops of assay diluent was added 
to the diluent well. The result was interpreted within 20 to 30 minutes by 
viewing through the result window. 
Interpretation: 
Positive result: 
Plasmodium falciparum infection: Appearance of color band in the T1 
region together with a band in the C region. 
Non-falciparum malarial infection: Appearance of color bands in the 
T2 region together with a band in the C region. 
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Plasmodium falciparum or a mixed infection of Plasmodium 
falciparum with other species: Appearance of color bands in T1, T2 
region together with a band in the C region. 
Negative result: 
Appearance of a color band in the C region with no bands in any of 
the T regions indicates a negative result. 
 Invalid result: 
Failure of appearance of color band in the C region indicates an 
invalid test. 
Enzyme Linked Immunosorbent Assay for the detection of parasite 
specific pan malarial antigen (pLDH): 
Procedure: 
All the reagents and specimen were brought to room temperature. 
Required numbers of microwells were taken out of the pouch. Datasheet 
was prepared and the location of the controls and specimen recorded. 
Two positive controls and two negative controls were used per test 
run.100µl of sample diluent containing diluted antibody reagent was 
added to each well. 25µl of positive control, negative control, 
sample(whole blood) were added to the respective wells. Microwell plate 
was gently shaken to mix the contents; microwells in the plate were 
sealed and incubated at 370C for 30 minutes. Each well was washed with 
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350µl of diluted wash buffer for six times and blotted dry. 100µl of 
diluted conjugate was added to each well and incubated at room 
temperature for 30 minutes. Each well was washed with 350µl of diluted 
wash buffer for six times and blotted dry. 100µl of substrate was added to 
each well and incubated at room temperature away from light for 
30minutes. 100µl of stop solution was added to each well in the same 
order as that of substrate to stop the reaction. The absorbance of each well 
was read at 450nm with 600-700nm as reference within 30 minutes of 
stopping the reaction. 
Cutt-off value calculation: 
 Cutt-off value = 0.1+Average of Negative control. 
Interpretation:  
• Samples with absorbance value more than the cutoff value:  
REACTIVE. 
• Samples with absorbance value less than the cutoff value:                  
NON-REACTIVE. 
Reactive samples are retested in duplicate. If both or either of the 
duplicate is reactive, the probability of malaria infection is high. 
Polymerase Chain Reaction: 
Genomic DNA extraction:  A 1.5 ml tube was taken, 20µl of    
Proteinase K was added followed by addition of 200µl of plasma and   
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200 µl of binding buffer. The tube was then vortexed well and incubated 
at 600C for 10 minutes. 100 µl of isopropranol was added and mixed well 
by pipetting. The lysate (Proteinase K + Plasma + Isopropranol) was then 
transferred to the upper reservoir of the binding column tube (fit in a 2ml 
tube) without wetting the rim. The tube was closed and then centrifuged 
at 8,000 rpm for one minute. The binding column tube was then 
transferred to a new 2 ml tube. 500 µl of washing buffer (1) was added to 
the binding column tube and centrifuged at 8,000 rpm for one minute. 
The solution collected in the 2ml tube was poured into a disposable 
bottle. Washing buffer (2) was then added to the binding column tube and 
centrifuged at 12,000 rpm for one minute. The binding column tube was 
then transferred to a new 1.5 conical bottom elution tube. 200µl of elution 
buffer added to binding column tube allowed to remain in the tube for 
one minute. The tube was centrifuged at 8,000 rpm for one minute. 
Approximately 200 µl of eluent was collected in the elution tube.  
Preparation for PCR amplification:  
 Desired numbers of PCR tubes were placed in the cooling block. 
All the reagents were thawed completely and mixed by brief vortexing. 
 The Real-time PCR was performed based on Taq-man principle. 
Malaria supermix which contains dNTPs, primers and probes is provided 
in a ready to use form. Master mix was prepared as in the flow chart 
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below. 15 µl of the master mix was added to each PCR tube. 10 µl of the 
DNA extract was added to appropriate sample tubes. 10 µl of standards 
added to positive control tube and 10 µl of PCR grade water added to 
negative control tube. The master mix and the DNA extract or standard 
thus added are mixed well by pipeting up and down. The PCR tubes 
closed and transferred to the rotor of the Rotor Gene 6000 instrument. 
Locking ring placed on the top of the rotor to prevent accidental opening 
of the tubes during the run. The thermal conditions were set as given in 
the table below. Data acquiring channel Green (FAM) and yellow (Joe) 
were set after setting the anealing temperature. Test was run. The data 
analysis performed using Rotor Gene™ software according to the 
manufacturer’s instructions. 
Interpretation: 
• If a signal is detected in fluorescence channel cycling A Green, 
sigmoid shaped curve is generated. If the Ct value is less than or 
equal to 37, the result of the analysis is positive i.e., the sample 
contains malaria DNA. Ct value more than 37 is considered as 
negative.  
Ct value: The cycle number when a sample crosses a threshold 
value is Ct value.  
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• If no signal is detected in fluorescence channel cycling A Green, 
the curve will be just above the threshold level or below the 
threshold level. It should be associated with amplification in 
yellow channel (which is due to internal control). The result of the  
analysis is negative i.e., the sample does not contain malaria DNA.  
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Preparation of master mix (as per the manufacturer’s instructions): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Malaria 
supermix  12µl 
 
 
Magnesium 
solution 
2.5µl 
 
IC-1 
0.5 µl 
Master mix 
15µl 
10µl of DNA extracted or 
standard or negative control 
For amplification 
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PCR thermal setting 
Repeat cycle 45 times 
 
 
 
 
Time 
 
Temperature 
 
Initial denaturation 
 
10 min 
 
950C 
 
3 step cycling 
 
Denaturation 
 
15 sec 
 
950C 
 
Anealing 
 
20 sec 
 
550C 
 
Extension 
 
15 sec 
 
720C 
  
Figure (i): Peripheral smear 
 
 
 
 
 
Figure (ii):  Peripheral smear of a 1 year old male child with fever for a week showing       
early ring forms (1,2) of  Plasmodium vivax
– Thick and thin smear 
. 
  
 
  
Figure (iii): Peripheral smear of a 45 year old male with fever for 10 days showing 
forms (1,2,3) of Plasmodium vivax with
                                  
 
Figure (iv): Peripheral smear of a 51 year male with fever, rigors and headache for 5 days 
showing amoeboid form(
 Schuffner’s dots and enlarged RBCs
2) and Early ring form (1) of  Plasmodium vivax.
Ring   
 
 
 
 
 Figure (v): Peripheral smear of the same patient showing a
Plasmodium vivax with schufners dots
     
              
   Figure (vi): Peripheral smear of a 54 year male with fever for 10 days showing  
   early schizont(1) and e
moeboid form of 
(1).  
arly ring form (2) of Plasmodium vivax.          
            
 
               
 
  
Figure (vii):  Peripheral smear of a 3 year old female child with cerebral                         
malaria showing early schizonts(2),
of  Plasmodium vivax with enl
 
 
Figure (viii): Peripheral smear of the same patient showing 
Trophozoite(2) and early ring form
 Trophozoite(1) and early ring form(3)                             
arged RBCs. 
mature schizont 
(3) of Plasmodium vivax and enlarge RBCs
 
 
(1), 
.  
 
  
Figure (ix): Peripheral smear of the same patient showing 
Plasmodium falciparum.
 
Figure (x): Peripheral smear of a 30 year male with fever
showing Gametocyte(1) 
 
Gametocyte (1) 
 
 for 10 days                            
of Plasmodium  falciparum. 
of         
 
 
  
 
 
 
 
 
 
 
Figure (xi): Immunochromatography Kit 
 
 
 
 
 
 
 
 
  
Figure (xii): ICT - Positive for non-falciparum malarial infection 
 
 
 
Figure (xiii): ICT - Positive for Plasmodium falciparum or mixed malarial infection  
 
 
 
Figure (xiv): ICT - Positive for Plasmodium falciparum infection or persistance of  pfHRP2 
 
 
 
  
Figure (xv): ELISA kit for pan-malarial pLDH enzyme detection 
 
 
 
 
Figure (xvi): Microtitre wells with controls and samples. 
Sample 1,2 & 3 are  positive for pLDH 
 
 
  
 
Figure (xvii): DNA extraction kit 
 
 
 
 
 
 
 
 
Figure (Xviii): DNA extraction 
 
 
 
 
  
 
 
 
 
 
Figure (xix): PCR kit for detection of malaria. 
 
 
 
 
 
 
 
 
 
 
  
 
                            Figure (xx): PCR instrument showing the rotor with master mix 
           and DNA extract loaded vials 
 
 
 
 
 
                    Figure (xxi): Samples loaded, programming done and  
                                               the test run started 
                             
  
 
         
     Figure(xxii): Report of  Qualitative RT-PCR  for malarial Parasite detection 
 
 
 
 
No. Colour Name Type Ct 
1 
 
s1 Standard 19.46 
2 
 
1 Unknown 29.17 
3 
 
5 Unknown NEG 
4 
 
36 Unknown 23.02 
5 
 
45 Unknown 21.97 
6 
 
66 Unknown 19.91 
7 
 
73 Unknown NEG 
8 
 
74 Unknown 34.46 
9 
 
75 Unknown NEG 
10 
 
80 Unknown 29.31 
11 
 
81 Unknown NEG 
12 
 
86 Unknown 23.69 
13 
 
lAB Unknown 20.76 
14 
 
nC NTC NEG 
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RESULTS 
During the study period from September 2011 to September 2012, 
a total of 242 blood samples (EDTA added whole blood) were collected 
from the patients clinically suspected to have malaria. Peripheral smear 
was considered as the Gold standard test. Peripheral smear, ICT, ELISA 
were done on all samples. PCR was done with plasma on 40 selected 
samples (20 peripheral smear positive and 20 peripheral smear negative 
samples). 
The statistical analysis of the qualitative data was done by using 
Statistical Package for Social Sciences (SPSS) version 17 software.         
P-values were obtained from Pearson Chi Square test. 
ICT, ELISA and PCR were compared with the Gold Standard 
peripheral blood smear. Sensitivity, Specificity, Positive Predictive Value 
(PPV) and Negative Predictive Value (NPV) were calculated and given 
with their estimate and 95% confidence interval. 
 The age of the patient under study ranged from 0 - 75 years. The 
commonest age group affected was 16 to 30 years (27.1%)                  
(Ref: Table 1). 
 The male: female ratio was 6:1 with 36 (85.71%) cases of male and 
6(14.29%) cases of female (Ref:Table 2). The highest incidence among 
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male was observed in the age group 16 to 30 years (18 cases), while 
among female, it was 0 to 15 years (4 cases) (Ref: Chart 2). 
 Seasonal variation was observed in this study. Maximum number 
of cases were observed during the month of September 2011 - 6/23 cases 
(26%) and September 2012 - 8/33 cases (24%), followed by          
October 2011 - 7/33 (21%) cases and August 2012 - 5/25 (20%) cases 
(Table 3). 
 Out of the 242 clinically suspected cases, 42 cases (17.4%) were 
positive for malarial parasite by thick and thin smear examination    
(Table 4).  
Of this, 39 were Plasmodium vivax, 2 were Plasmodium 
falciparum and one was a mixed infection with Plasmodium vivax and 
Plasmodium falciparum    (Table 4a).  
Out of the 242 clinically suspected cases, 44 cases (18.8%) were 
positive for malarial parasite by Immunochromatography test (Table 5). 
Of this, 34 were found to be non-falciparum malarial infection, 8 
were found to be either Plasmodium falciparum infection alone or a 
mixed infection of P.f with P.v / P.m / P.o and 2 were found to be either 
P.f infection or an indication of PfHRP2 persistence (Table 5a). 
When Microscopy and ICT were taken together to identify the             
species of the malarial parasite, 34 cases(14.05%)  were identified as    
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Plasmodium vivax, 2 cases(0.83%) were identified as Plasmodium 
falciparum and  6 cases(2.48%) were identified as a mixed infection with 
Plasmodium vivax and Plasmodium falciparum (Table 6). 
Out of the 242 cases tested by ELISA method for malarial parasite 
specific LDH, 43 cases (17.8%) were found to be positive (Table 7). 
Out of 20 microscopy positive cases selected for PCR, all were 
positive for malarial parasite. Of the 20 microscopy negative cases 
selected for PCR 4 were positive (Table 8). 
When ICT was compared with the gold standard microscopy, the 
sensitivity   was found to be 100%, specificity 99%, PPV 95.5% and NPV 
100% (Table 9). 
When ICT was compared with the microscopy for the detection of 
P.f or mixed infection, ICT had a sensitivity of 100%, specificity 98%, 
PPV 37% and NPV 100% (Table 10). 
When ELISA (pLDH) was compared with the microscopy, ELISA 
showed a sensitivity of 100%, specificity of 99.5%, PPV of 97.7% and 
NPV of 100% (Table 11). 
When PCR was compared with microscopy for detection of 
malaria, the sensitivity, specificity, PPV and NPV were 100%, 80%, 83% 
and 100% respectively (Table 12). 
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The confidence interval of sensitivity, specificity, PPV and NPV 
for ICT and ELISA were calculated and given in the (Table 13). As PCR 
was not done on all the samples, confidence interval cannot be calculated 
for the sensitivity, specificity, PPV and NPV of PCR. 
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Table – 1 
Age wise distribution of malaria positive 
cases 
Age in 
years 
Total 
no. 
of 
cases 
 
 
 
No. of 
cases 
Positive 
for 
malaria 
Percentage 
(%) 
0 – 15 85 11 12.9% 
16 – 30 70 19 27.1% 
31 – 45 56 7 12.5% 
46 – 60 27 5 18.5% 
>60 4 0 0% 
Total 242 42 17.3% 
  
 
 
 
 
 
 
Table –2 
Sexwise distribution of malaria positive cases(n=42) 
Sex 
No. of 
cases 
positive for 
malaria 
Percentage 
(%) Male:Female Ratio                
6:1 Male 36 85.71% 
Female 6 14.29% 
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             Table -3 
Seasonal distribution of malaria from Sep’11-Sep’12 
Month 
Total no. 
of 
samples 
No. of 
positives 
Percentage 
(%) 
2011 
September 23 6 26% 
October 33 7 21% 
November 30 4 13.3% 
December 21 4 19% 
2012 
January 9 0 0 
February 8 0 0 
March 8 0 0 
April 5 0 0 
May 13 2 16.6% 
June 18 3 16.6% 
July 16 3 18.7% 
August 25 5 20% 
September 33 8 24% 
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Table – 4 
                              Results of  microscopy 
Total no. 
of Blood 
smears 
examined 
Smears positive for malarial parasite 
 
Thick 
smear 
Thin 
smear Total % 
242 42 42 42 17.4% 
 
 
 
 
 
              
Table –4a 
Distribution of Plasmodium species as identified by 
Thin smear (n=42) 
Species 
No. of 
positives 
Percentage 
(%) 
Plasmodium vivax 39 92.8% 
Plasmodium falciparum 2 4.8% 
Mixed infection 
(P.v&P.f) 1 2.4% 
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Table –5 
Results of  Immunochromatography test 
Total no. of  
samples 
No. of 
positives Percentage (%) 
242 44 18.18% 
 
 
 
 
 
 
 
Table –5a 
Distribution of Plasmodium species as identified by ICT 
(n=44) 
Species 
No. of 
positives Percentage (%) 
Non-falciparum 
malarial infection 34 77.3% 
Pf  infection or 
mixed infection 8 18.2% 
Pf  infection or 
persistence of  PfHRP2 2* 4.5% 
        
        
        Pf  - Plasmodium falciparum 
        PfHRP2 – Plasmodium falciparum specific Histidine Rich Protein 2. 
       * 2 cases indicating Pf infection or persistence of  PfHRP2  was      
found to be  due to persistence of PfHRP2. 
 
 
50 
 
 
 
 
 
 
Table -6 
Distribution of  Plasmodium species as  identified by 
combination of Microscopy and ICT 
 
        
 
 
 
 
 
Species 
No. of 
positives by 
Microscopy 
No. of 
positives          
by ICT 
Microscopy     
& ICT taken 
together for 
speciation 
(n=42) 
No. % 
Plasmodium vivax 39 34 34 80.9% 
Plasmodium 
falciparum 2 
8 
2 4.8% 
Mixed infection 
 
(P.v&P.f) 
1 6 14.3% 
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                                                Table –7 
Results of ELISA(pLDH) 
Total no. of samples 
tested 
No. of 
positives 
Percentage
(%) 
242 43 17.8% 
 
 
 
 
 
Table –8 
Positivity of malarial parasite by various technique among 
the 40 samples selected for PCR 
Test 
 
Positive by 
microscopy       
(n=20) 
Negative by 
microscopy 
(n=20) 
ICT positive 20 2 
ELISA(pLDH) positive 20 1 
PCR positive 20 4 
 
 
Among the 20 microscopy negative samples selected for 
PCR, PCR has detected 4 cases as positive for malaria, 
ELISA has detected one case as positive for malaria which 
was also detected positive by PCR and 2 cases detected by 
ICT as PfHRP2 positive but pLDH negative, were negative 
by PCR. 
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Table -9 
Cross tabulation of ICT results by Microscopy (n=242) 
ICT 
Microscopy 
Total Positive Negative 
Positive 42 2 44 
Negative 0 198 198 
Total 42 200 242 
 
Sensitivity 
(%) 
Specificity 
(%) 
PPV   
(%) 
NPV 
(%) 
Pearson   chi-square test 
Value df p-value 
100 99 95.5 100 228.690 1 0.000 
 
 df = degree of freedom. 
 
ICT shows excellent sensitivity, specificity and Negative 
Predictive Value, with good Positive Predictive Value in detecting 
malarial infection when compared to microscopy. p-value is 0.000 
(p-value should be less than 0.005). Thus it is statistically 
significant. This shows that ICT is more sensitive than microscopy. 
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Table – 10 
Cross tabulation of ICT(Pf or mixed infection) by                           
microscopy (n=242) 
ICT(Pf or 
mixed 
infection) 
Microscopy 
Total Positive Negative 
Positive 3 5 8 
Negative 0 234 234 
Total 3 239 242 
 
Sensitivity 
(%) 
Specificity 
(%) 
PPV   
(%) 
NPV 
(%) 
Pearson   chi-square test 
Value df p-value 
100 98 38 100 89.227 1 0.000 
 
 
ICT shows excellent sensitivity and Negative Predictive Value,    
with good specificity in detecting P.f or mixed malarial infection 
when compared to microscopy. p-value is 0.000 (p-value should 
be less than 0.005). Thus ICT being  more sensitive than 
microscopy in detecting mixed infection and Plasmodium 
falciparum is statistically significant.  
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Table-11 
Cross tabulation of ELISA results by Microscopy 
(n=242) 
ELISA 
Microscopy 
Total Positive Negative 
Positive 42 1 43 
Negative 0 199 199 
Total 42 200 242 
 
               
Sensitivity 
(%) 
Specificity 
(%) 
PPV   
(%) 
NPV 
(%) 
Pearson   chi-square test 
Value df p-value 
100 99 98 100 235.190 1 0.000 
 
 
ELISA shows excellent sensitivity, specificity and Negative 
Predictive Value, with good Positive Predictive Value in detecting 
malarial infection when compared to microscopy. p-value is 0.000 
(p-value should be less than 0.005). Thus ELISA being more 
sensitive and specific than microscopy in detecting malarial 
infection is statistically significant.  
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Table -12 
Cross tabulation of PCR results by microscopy 
(n=40) 
PCR 
Microscopy 
Total Positive Negative 
Positive 20 4 24 
Negative 0 16 16 
Total 20 20 40 
 
 
Sensitivity 
(%) 
Specificity 
(%) 
PPV   
(%) 
NPV 
(%) 
Pearson   chi-square test 
Value df p-value 
100 80 83 100 26.667 1 0.000 
 
 
PCR shows excellent sensitivity and Negative Predictive Value in 
detecting malarial infection when compared to microscopy. p-value 
is 0.000 (p-value should be less than 0.005). Thus PCR being  more 
sensitive  with excellent Negative Predictive Value  is statistically 
significant. 
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Table –13 
Evaluation of recent techniques in the diagnosis of malaria 
Test 
Sensitivity(%) 
CI(%) 
Specificity(%) 
CI(%) 
PPV(%) 
CI(%) 
NPV(%) 
CI(%) 
ICT 
100% 
(92 - 100%) 
99% 
(96 – 100%) 
95% 
(85 – 99%) 
100% 
(98 – 100%) 
ICT (Pf  or    
mixed infection) 
100% 
(44 – 100%) 
98% 
(95 – 99%) 
38% 
(14 – 69%) 
100% 
(31 – 86%) 
ELISA(pLDH) 
100% 
(92 – 100%) 
99% 
(97 – 100%) 
98% 
(88 – 100%) 
100% 
(98 – 100%) 
PCR 100% 80% 83% 100% 
 
        CI: 95% Confidence Interval. 
 Thus, ICT and ELISA are equally sensitive (100%) and specific     
(99%) in detecting malarial infection. But ICT shows false 
positives, whereas ELISA do not. Of the three tests studied, PCR is 
the most sensitive (100%) with excellent Negative Predictive 
Value (100%). 
  
PCR was not done on all the samples. Thus CI cannot be 
calculated. 
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DISCUSSION 
  In this study, blood samples from 242 clinically suspected 
cases of malaria were subjected to microscopy, ICT, ELISA. Out of 242 
samples, PCR was performed on 40 samples. 
 Malarial parasite was detected in 42 cases out of the total 242 
clinically suspected cases of malaria by both thick and thin smear 
(17.4%).  Out of 42 cases, 39 were found to be Plasmodium vivax 
(92.8%), 2 were found to be Plasmodium falciparum (4.8%) and one was 
mixed infection with Plasmodium vivax and Plasmodium falciparum 
(0.41%).  
 The commonest age group affected was 16 to 30 years (27.1%). 
Males were found to be affected with malaria more than the females.     
P-value was 0.001(p<0.005). Hence the difference in distribution of 
malaria positive cases in male and female was found to be statistically 
significant. The male: female ratio was 6:1. The reason for this was males 
were involved in more outdoor activities like agriculture and construction 
work. The females were mostly indoor and better clothed.  
Seasonal variation was observed in this study. The peak incidence 
was observed in September and October which coincides with monsoon. 
Rainfall and increased humidity paves way for breeding and survival of 
mosquitoes.  
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Of the 42 positive cases, 12 were associated with history of travel 
to malaria endemic areas like Uttar Pradesh, Delhi, Bihar, Rajasthan, 
Orissa, Andhra Pradesh, Calcutta, and Chennai. This is because people 
from these places come to Coimbatore for business purpose or as contract 
workers for construction work. This also explains the common age group 
affected in this study and increase in incidence among males. 
 The incidence of malaria in this study is comparable with the 
following studies: 
 Parija et al at Pondicherry, India, in June 2009, reported 82 
samples (19.95%) positive for malarial parasite out of 422 clinically 
suspected samples tested by peripheral smear 31. 
 The study by Bhat Sandhya k et al in 2012, reported 13.2% 
(66/500) of the cases positive by thick smear and 12% positive by thin 
smear examination in their study at Tumkur, Karnataka. Of this, 6.6% 
were Plasmodium falciparum, 4.6% were Plasmodium vivax and 0.8% 
was mixed infection 48. 
 Manjunath P Salmoni, et al at Bijapur , Karnataka, in 2011, had 
reported 15.5% (60/387) of cases positive by  Leishman stained thick 
smear and 10.6%(41/381) of cases (P.v 48.8%, Pf 43.9%, mixed infection 
7.3%)  positive by Leishman stained thin smear 49.  
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 A hospital based study by Kavitha Prabhu, et al at Davangere 
district of Karnataka, in 2010, reported 10.9% (22/202) cases positive for 
malaria (Pf 68.2%, Pv 13.6% and  mixed Pv & Pf infection13.6%) 50. 
  Mahadev.S.Harani, et al , 2006, in their study at Karachi had 
reported 12.5% (72/560) of clinically suspected cases positive by 
Peripheral smear(Pf 32, Pv 29 and mixed infection with Pv & Pf 4 out of 
560) 51. 
 In this study, the predominant species was identified as 
Plasmodium vivax which is comparable to the studies by Manjunath P 
Salmoni et al 49, A.H.Moon et al 52 and Shamim Akhtar et al 53. 
  Kavitha Prabhu et al 50, Mahadev.S.Harani et al 51 and             
Bhat Sandhya k, et al 48 in their studies had detected P. falciparum as the 
predominant species which is in contrast to this study. 
 Thus, the incidence and species distribution varies from country to 
country worldwide and also from region to region within a country. 
ICT 
 In this study, out of 242 clinically suspected cases of malaria, 44 
were positive for the presence of malarial parasite (18.18%) by ICT.  
Of this 34 cases (77.3%) were non-falciparum malaria infection, 8 
cases (18.2%) were found to be either Plasmodium falciparum alone or a 
mixed infection. 
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The disadvantage with the ICT used in this study is that, it cannot 
speciate the non-falciparum malarial infection and cannot distinguish a 
falciparum malarial infection from mixed infection of falciparum malaria 
with other Plasmodium species. 
         The 34 cases detected as non-falciparum malaria by ICT, were 
identified as asexual stages of Plasmodium vivax by peripheral smear. 
Thus the samples which were positive for pLDH (pan malarial antigen)    
i.e., samples which showed C & T2 lines by ICT were considered as 
Plasmodium vivax. 
Eight ICT cases which showed positive for both pLDH and 
PfHRP2 were compared with microscopy for speciation. Out of               
8 cases, two were identified as Plasmodium falciparum infection by 
microscopy. Thus these 2 cases were positive for P. falciparum. Six were 
positive for Plasmodium vivax by microscopy whereas the ICT showed 
Plasmodium falciparum in addition to Plasmodium vivax. Thus, these 6 
cases were mixed infection of Plasmodium vivax and P.falciparum. 
Microscopy failed to detect Plasmodium falciparum infection in these 6 
cases.        
Two cases were positive for PfHRP2 alone by ICT. These cases, 
when looked into the history of the patient, were follow-up cases. Blood 
samples examined from these two cases, two weeks prior to this sampling 
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were positive for mixed infection and they showed clinical recovery with 
appropriate antimalarial treatment. In the follow-up sample (after 2 weeks 
of appropriate antimalarial treatment), pLDH had disappeared which 
indicated the response to treatment. PfHRP2 did not disappear because of 
its property of persisting in the blood for upto 28 days even after the 
disappearance of the parasite. Microscopy was negative for malarial 
parasite. Both the samples were negative for malaria by ELISA for pLDH 
and RT-PCR. Thus these 2 cases were due to persistence of the PfHRP2 
enzyme and not Plasmodium falciparum infection. 
Of the total malaria cases (42/242) detected in this study, 34 were 
Plasmodium vivax, 2 were Plasmodium falciparum and 6 were mixed 
infection with Plasmodium vivax and Plasmodium falciparum when 
microscopy and ICT were taken together for speciation. 
 The sensitivity of the ICT test to detect malarial parasite was 
100%, specificity 99%, PPV 95.5% and NPV 100%.  p - Value of ICT 
versus microscopy obtained by Pearson chi-square test was found to be 
0.000 (p<o.oo5) and is found to be statistically significant. 
There is a reasonable harmony between ICT and microscopy in 
detection of malarial parasite though there is variation in identifying the 
species. Similar results were obtained in the study Panchal H and      
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Desai Pratibha (2012) 54, Bhat Sandhya K et al (2012) 48 with SD Bioline 
malaria antigen kit.  
This study revealed that ICT is highly sensitive in detecting the 
malarial parasite which is similar to the study by Wanna Chaijaroenkul   
et al (2010) 55.  
ICT detected all Plasmodium vivax infection identified by 
microscopy. A study by Lt col MN Mishra and Surg capt RN Misra 
(2007) had reported a sensitivity and specificity of 100% for detection of 
Plasmodium vivax by ICT 29.  
The following studies are contradictory to this study.              
Arsene Ratsimbasoa et al (2008) stated that SD bioline malaria Pf/pan 
test had much lower sensitivity (63%) in detecting non-falciparum 
malarial parasites 56. A study by Heidi Hopkins et al (2007) 57 and    
Pankaj P.Taviad et al (2011) 58 had reported that pLDH was less sensitive 
(85%) but 100% specific in detecting the parasite. Mahadev S.Harani     
et al (2006), in their study had 89.7% sensitivity in detecting the 
Plasmodium vivax 51. 
The diagnostic performance of ICT for Plasmodium falciparum or 
mixed infection was as follows: Sensitivity 100%, specificity 97.91%, 
PPV 37.5% and NPV 100%.  
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ICT is better than microscopy in identifying the mixed infection, 
especially the Plasmodium falciparum with other species. Out of 6 mixed 
infections, 5 were identified as Plasmodium vivax by microscopy and 
thus, it failed to detect Plasmodium falciparum. The reason for this is the 
character of the Plasmodium falciparum to sequester in the blood vessels 
of internal organs and lesser availability of the schizonts in the peripheral 
blood. Hence the parasite is not visible in the peripheral smear. In ICT, 
we are detecting the enzymes or proteins to identify the parasite - which 
is present in the blood even during the sequestration of the parasite. The 
following studies are comparable to this study. 
In a Study by Wanna Chaijaroenkul et al (2011) 55, ICT Pf/Pan had 
detected more number of Plasmodium falciparum infection when 
compared to microscopy. A Study by Arsene Ratsimbasoa et al (2008) 56 
reported sensitivity and specificity of 92.9% and 98.9% respectively for 
Plasmodium falciparum detection. Mahadev S.Harani et al (2006) 51, in 
their study had found a good diagnostic performance of 94.91% 
sensitivity, 96.21% specificity in detecting the Plasmodium falciparum. 
Praveen K Bharti et al in 2008 59, in their study found that the overall 
sensitivity of RDT in detecting Plasmodium was 93% but, its accuracy in 
detecting non-falciparum malaria was less than that of detecting 
Plasmodium falciparum.  
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 Kavitha Prabhu et al in 2010 50, reported that ICT has                    
the advantage of being highly sensitivity to detect the               
Plasmodium falciparum infection. In their study, out of 202 cases, 20 
cases were positive for malarial parasite. ICT had detected 6 cases 
negative by microscopy. Of these 6 cases, 4 were identified as   
Plasmodium falciparum and 2 were false positives. 
The complications of malaria were associated with mixed infection 
(Plasmodium falciparum and Plasmodium vivax) in this study. Out of the 
6 patients diagnosed to have mixed infection 2 had cerebral malaria.  
One of the patients with mixed infection was a10 year old male 
child. He presented with fever, haematuria and prostration. Blood 
investigation revealed mixed infection of Plasmodium falciparum with 
Plasmodium vivax, anaemia (Hb 6 g/dl) and thrombocytopenia (platelet 
count – 50,000/cumm). He was treated with antimalarial drugs 
(Artemesinin combination therapy), inspite of which fever persisted. 
Anaemia was corrected with blood transfusion. After 10 days, a follow up 
sample was tested for malaria. Peripheral smear was negative for malarial 
parasite. ICT showed disappearance of pLDH which means there was no 
live asexual stages of malaria parasite in the blood but, PfHRP2 persisted. 
ELISA for pLDH and RT- PCR were also negative for malaria. He was 
investigated for other causes of fever. Urine culture revealed growth of 
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Klebsiella oxytoca (on day 28 of illness). He was treated with appropriate 
antibiotics for one week but continued to have fever. A blood sample was 
again tested for malaria by microscopy and ICT methods (on day 38 of 
illness). Microscopy revealed ring stages and schizonts of Plasmodium 
vivax. ICT was positive for pLDH and there was no line in the PfHRP2 
region. It is a relapse of Plasmodium vivax infection. Patient was treated 
with Chloroquine and Primaquine for which he responded and was 
discharged.  
It is evident from this case that relapse occurs in Plasmodium vivax 
infection. Also, severe malaria predisposes to bacteremia especially 
Respiratory tract and urinary tract infections particularly in children as 
stated by Gordon C Cook and Alimuddin I Zumla 1.                                     
Another patient among the six who were diagnosed to have mixed   
infection had anaemia (Hb 5g/dl) and splenomegaly who responded to 
antimalarials. Blood transfusion was given to correct anaemia.  
Two patients with mixed infection did not have any complications 
and responded to antimalarials. 
In mixed infection, the Plasmodium falciparum is the cause for 
complications because of its property of adherence to the blood vessels of 
internal organs like brain. ICT detected all the mixed infections (6/42). 
Peripheral smear detected only one mixed infection and detected other 
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five as Plasmodium vivax infection.  ICT helped in diagnosing the mixed 
infections particularly with Plasmodium falciparum and thus the patient 
was treated appropriately. 
ELISA  
In this study, out of 242 clinically suspected cases of malaria, 43 
were positive for malarial parasite (17.8%) by ELISA (pLDH).  
The sensitivity, specificity, PPV and NPV of ELISA when 
compared with the gold standard was 100%, 99%, 97.7% and 100% 
respectively. Pearson chi-square test was done for ELISA vs. microscopy 
and p value was found to be 0.000 (p<0.005). Thus the better diagnostic 
performance of ELISA when compared to microscopy is found to be 
statistically significant. 
One case which was detected positive for Plasmodium species by 
ELISA was negative by microscopy and ICT method. This patient 
presented to the medicine department with 10 days of fever. He was 
diagnosed outside to have malaria by ICT method (for malarial 
antibodies) and was treated with a course of chloroquine. The patient had 
persistant fever and was admitted in Coimbatore Medical College 
Hospital. He was investigated for the cause of fever. His peripheral smear 
was negative for malarial parasite. ICT was negative for pLDH and 
PfHRP2 antigens. ELISA for parasite specific pan malarial antigen was 
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positive. The sample was tested for ELISA (pLDH) in duplicates which 
were also positive. This was confirmed by RT-PCR. Speciation was not 
done by ELISA method in this study. The patient responded to 
antimalarial treatment. ELISA is more sensitive and specific especially in 
cases with persistance of infection due to low parasitemia. 
RT-PCR 
 RT-PCR was done for 20 microscopy positive cases of malaria. 
These cases were also positive by ICT and ELISA. Seventeen cases 
which were negative for malaria by microscopy but highly suspected to 
have malaria clinically with other investigations for Pyrexia of unknown 
origin being insignificant were subjected to PCR. Two cases negative by 
microscopy and ELISA for malaria but, positive for PfHRP2 by ICT and 
One case positive for malaria by ELISA but negative by other two 
methods were also subjected to RT-PCR. All microscopy positive cases 
were positive for malaria by RT-PCR. The case which was positive for 
malaria by ELISA alone was positive by RT-PCR. Two cases positive for 
PfHRP2 by ICT was negative for malaria by RT-PCR. Of the 17 cases 
negative for malaria by microscopy, ICT and ELISA, 3 were detected 
positive by RT-PCR. 
All the patients detected to have malaria by RT-PCR were treated 
with antimalarials.  Patients responded to treatment.  
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The sensitivity of RT-PCR, when compared with the gold standard 
was 100%, specificity was 80%, PPV was 83.3% and NPV was 100%. 
F.Perandin et al in 2004, had evaluated TaqMan-based real-time 
PCR for diagnosis of malaria. RT –PCR was compared with microscopy 
and nested PCR. The RT-PCR is highly sensitive (100%) and specific 
(100%) when compared to nested PCR for simultaneous detection of 
three Plasmodium species. Also it brought to light the errors in species 
identification by microscopic examination 60. 
Bhavna Gupta in their study in 2010 at New Delhi, India, had 
reported a higher percentage of mixed infection was detected by PCR 
when compared to microscopy. In India, highest proportion of mixed 
infection was seen in Chennai samples 61. 
Fracas et al in 2004 evaluated a real time PCR assay and reported a 
sensitivity of 99.5%, specificity of 100%, positive predictive value of 
100%, and negative predictive value of 99.6% for the detection of malaria 
when compared to nested PCR as the standard reference 41. 
Brian J Taylor et al in 2011 conducted a study in Colombia. Here 
Real-time PCR was performed directly on whole blood and filter paper 
samples for detection of plasmodium DNA. The sensitivity and 
specificity ranged from 93 to 100% compared with the PCR performed 
on purified Plasmodium DNA 62. 
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  Prapaporn Boonma et al, 2007, in their study at Thailand, 
compared three molecular methods with microscopy. Real-time PCR 
showed a sensitivity and specificity of 100 and 97% for P.falciparum, 
87.5 and 93% for Plasmodium vivax, 50% and 99.2% for mixed infection. 
Real-time PCR was concluded as the best molecular method of the three 
(nested, multiplex and Real-time PCR) in their     study 63. 
Shokoples SE et al in 2009, in their study had stated that when  
RT-PCR was compared with microscopy, PCR demonstrated a greater 
sensitivity for the speciation of low level infections, mixed infections, and 
differentiation of “non-falciparum” species 64. 
The above studies are comparable to this study in the sensitivity of 
detecting the malarial parasite. Speciation was not done by PCR in this 
study. 
PCR, though has a high sensitivity in detecting malarial parasites, 
it has limitations in using as a routine diagnostic method in view of its 
cost, need for experienced person, continuous electricity supply and 
availability in all hospitals.  
RT-PCR, when compared to the conventional PCR has a short 
turn-around time of only 3 hours and less chance of cross-over 
contamination. This shorter turnaround time could rapidly identify 
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undiagnosed or misdiagnosed cases, with an early, direct impact on 
patient management. 
For a peripheral smear to be stained and examined thoroughly for 
malarial parasite, it needs a maximum of one hour. Speciation can be 
done and it is very cheap.  
Though the peripheral smear has these advantages, it fails to detect 
Plasmodium falciparum infection when the parasites are sequestered in 
the blood vessels of internal organs and non-falciparum malarial parasites 
when the parasitemia is low.  
In this study RT-PCR had detected 4 malaria positive cases which 
were not detected by the peripheral smear. The reason for failure to detect 
malarial parasite by peripheral smear was low parasitemia due to intake 
of antimalarial drug intake prior to submission of sample for 
investigation.  
The cycle threshold (Ct) for the standard (concentration – 
25000000 copies) used in this study was 19.46. The cycle threshold for 
the positive samples detected by microscopy was between 19.91 and 
29.31. The cycle thresholds of the four samples negative by microscopy 
were 35.1, 37.0, 36.13 and 34.46. 
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Thus, RT-PCR because of its high sensitivity, it can be used as a 
second line diagnostic tool and as a confirmatory test in the diagnosis of 
malaria especially in a tertiary care hospital or reference laboratories with 
facilities to perform molecular methods as stated by S C Parija 65, Fracas 
et al 41, Berry A et al 66, Tham et al 67 and Stephanie P. Johnston et al 68.  
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SUMMARY 
• This cross-sectional study was done over a period of 13 months 
and the study population comprised of 242 patients clinically 
suspected to have malaria. 
• The commonest age group affected was 16 – 30 years. 
• There was a male preponderance with male: female ratio of 6:1.  
• Seasonal variation in the distribution of malaria was observed and 
maximum number of positive cases occurred in September and 
October. 
• All the samples were subjected to microscopic examination of 
Leishman stained peripheral smear, Immunochromatography, 
ELISA for parasite specific pan-malarial LDH. RT-PCR was done 
on 40 samples. 
• Microscopy detected 42 cases (17.4%), ICT was able to detect 44 
cases (18.8%) and ELISA was able to detect 43 cases (17.8%).  
• 20 cases detected positive by microscopy were also detected as 
positive for malarial parasite by RT-PCR. Of the 20 cases detected 
as negative by microscopy, RT-PCR detected 4 cases as positive 
for malaria. 
73 
 
• Microscopy detected 39 as Plasmodium vivax, two as        
Plasmodium falciparum and one as mixed infection with 
Plasmodium vivax and Plasmodium falciparum. 
• ICT detected 34 cases as non-falciparum malaria and 8 cases as 
Plasmodium falciparum infection or mixed infection. 
• When microscopy and ICT were taken together for           
speciation, 34 were identified as Plasmodium vivax, 2 as                 
Plasmodium falciparum and 6 as mixed infection with   
Plasmodium vivax and Plasmodium falciparum. 
• Plasmodium vivax was found to be the predominant species in 
Coimbatore. 
• Complications due to malaria were commonly associated with 
mixed infection. 
• Microscopy was taken as the gold standard test and ICT, ELISA 
and PCR were evaluated for their diagnostic performance. 
• All the three recent diagnostic methods (ICT, ELISA and PCR) 
were found to be 100% sensitive when compared to microscopy in 
the diagnosis of malaria. 
• Microscopy is cheaper and able to speciate but, it is labour 
intensive, needs expertise and time consuming when compared to 
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ICT. Also it failed to detect mixed malarial infection in 5 cases in 
this study. 
• ICT is a rapid diagnostic test, simple to perform and does not need 
expertise. The diagnostic kit used in this study can be stored at 
room temperature away from direct sunlight. It is most suitable for 
field conditions. 
• ICT detected the mixed infection of Plasmodium vivax and 
Plasmodium falciparum in 6 cases in this study. It can be used in 
all levels of health care centres as an adjunct to microscopy. 
• Enzyme pLDH in ICT helps to detect response to treatment.  
• The limitation of ICT is, it is costlier than microscopy and the 
persistence of PfHRP2 results in false positivity which occurred in 
2 cases in this study. 
• ELISA for pLDH has a good diagnostic performance in detection 
of malaria, when compared with microscopy. There was no false 
positivity. It detected a case of malaria which was negative both by 
microscopy and ICT. It can be used in blood banks where large 
numbers of samples have to be screened. 
• RT – PCR is 100% sensitive in detection of malaria, when 
compared with microscopy. It is more sensitive than ICT and 
ELISA. It serves as a diagnostic tool in identifying cases with low 
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parasitemia and thus helps in appropriate management of the 
patient.  The limitation is the    cost, availability of equipment and 
need for specially trained technicians. 
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CONCLUSION 
 Though malaria is a disease of antiquity and there are many 
diagnostic methods from Peripheral smear to PCR, in many situations 
it is a diagnostic challenge to the physician because patients present 
with varied symptoms from simple fever to cerebral malaria. Also the 
typical fever pattern of malaria is masked due self-medication by the 
patients before consulting the physician. The availability of ‘over the 
counter drugs’ which includes antibiotics in our country makes the 
situation even more difficult. Antibiotics like sulpha drugs and 
fluoroquinolones have antimalarial effect and decrease the level of 
parasites in the peripheral blood thus, making it difficult to diagnose 
malaria by peripheral smear or ICT. ELISA and RT-PCR are better 
diagnostic methods in this situation. The advantages and limitations of 
different diagnostic methods of malaria have to be borne in mind and 
patients should be investigated thoroughly with appropriate diagnostic 
method, before claiming them negative for malaria. 
 From this study, it is evident that, the non-microscopic diagnostic 
methods have good diagnostic performance in detecting the malarial 
parasite. ELISA is more sensitive and specific with good Positive 
Predictive Value and excellent Negative Predictive Value. In view of 
its high sensitivity, it can be used in blood banks. The limitation with 
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ELISA method (detection of panLDH) used in this study is, it is not 
able to speciate. Speciation is necessary to decide the antimalarial 
drug to be prescribed to the patient.  With ELISA for pLDH, it is 
possible to follow the patient’s response to treatment. It also has the 
ability to detect malaria in cases of low parasitemia (below the level of 
detection by microscopy), especially when samples are submitted to 
the laboratory after initiation of antimalarial therapy. 
 RT-PCR shows an excellent sensitivity and Negative Predictive 
Value when compared to microscopy, thus allowing the exclusion of 
malaria in cases of Pyrexia of Unknown Origin in a tertiary care 
hospital. The turnaround time for RT-PCR is 3 hours which is rapid 
when compared to conventional PCR but when compared to 
microscopy and ICT, it is time consuming, needs equipments and 
round the time electricity supply in addition to an expertise to run the 
test. Limitations of RT-PCR performed in this study are inability to 
differentiate among four Plasmodium species and high cost per test 
when compared to microscopy and ICT. 
 ICT used in this study has advantages over ELISA and PCR in that 
it is able to detect Plasmodium falciparum and non-falciparum 
malarial infections. It is a rapid, highly sensitive and specific test with 
excellent Negative predictive value. It is superior to microscopy         
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in detecting Plasmodium falciparum or mixed infection of 
Plasmodium falciparum with other Plasmodium species. ICT can be 
used as an initial investigation in critically ill patients particularly 
when cerebral malaria is suspected in whom the parasites may be 
sequestrated. A limitation with this ICT is its inability to differentiate                 
non-falciparum malarial infection and to differentiate whether it is               
Plasmodium falciparum infection alone or it is a mixed infection.    
ICT also shows false positives. Use of ICT and microscopy for all the 
samples in a health care centre would help in speciation and detecting 
all mixed infections. Thus ICT can be used as an adjunct to 
microscopy in the diagnosis of malaria in a tertiary care centre.  
  Thus non-microscopic method like ICT is a good adjunctive 
to microscopy in diagnosis of malaria, ICT and ELISA are good 
alternatives to microscopy in blood banks because of their high 
sensitivity and  RT-PCR is the best method in diagnosis of malaria 
especially in cases of Pyrexia of Unknown Origin with  parasitemia 
below the detection limit of peripheral smear.
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WHO World Health Organization 
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RDT Rapid Diagnostic Test 
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RT-PCR Real Time - Polymerase Chain Reaction 
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HRP Histidine Rich Protein 
NVBDCP National Vector Borne Disease Control Programme 
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NIMR National Institute of Malarial Research 
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APDS Automated parasite detection system 
PMA Pan Malarial Antigen 
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P.v Plasmodium vivax 
P.f Plasmodium falciparum 
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P.o Plasmodium ovale 
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IC Internal Control 
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NPV Negative Predictive Value 
 (v) APPENDIX 
Requirements for Proper Smear Preparation: 
1) Clean grease free glass slide of size 75x25x1.5mm & a spreader 
2)  A blood drop of size 2 – 3 mm 
3)  The drop should be spread quickly and smoothly. 
4)  Smear should be dried. 
5)  Smear should be prepared within an hour of collection of blood. 
 Thin smear preparation:  
1. Sample should be mixed well. 
2. The side of the smear and the patient’s ID number marked on the 
slide. 
3. The slide should be kept on a flat surface,  a 2-3 mm drop of mixed 
whole blood is placed on the slide about 1/4 inch from the right 
side of the slide, using the wooden applicator sticks held in the 
right hand.   
4. The slide should be held securely in the left hand and the spreader 
slide held in the right hand between thumb and forefinger. 
5. The spreader slide is placed onto the lower slide in front of the 
blood drop at an angle of 450C, and the slide pulled back until it 
touch the drop. 
 
 6. The blood is allowed to spread by capillary action almost to the 
edge of the lower slide. 
7. The spreader slide is lowered to 300C and pushed forward to the 
left till the blood is exhausted using a rapid and even motion.   
8. The film is then allowed to air dry.  
Thick smear preparation: 
1. Sample mixed well.  
2. A big drop of blood is placed on a slide and spread with corner of 
another slide to form an area of a half-inch square and allowed to 
dry. The thickness of the film should be such that it allows 
newsprint to be read or the hands of the wrist watch to be seen 
through the dry preparation. 
Constituents of Leishman’s stain: 0.15 g of Leishman powder in 
100ml of acetone free methyl alcohol. 
ICT kit components: 
1. Malaria Ag P.f/Pan test device 
           2. Assay diluent 
     3. Disposable sample applicator 
ELISA kit components: 
1. Microwells coated with monoclonal anti p-LDH antibody. 
2. Positive control – Goat anti-mouse serum with stabilizer. 
 3. Negative control - Bovine serum albumin with stabilizer. 
4. Enzyme conjugate – Streptavidin HRP conjugate. 
5. Conjugate diluents – Buffered solution containing stabilizing 
proteins and preservatives. 
6. Antibody reagent – Biotinylated anti-pLDH antibody.  
7. Sample diluents – Buffered solution containing stabilizing proteins 
and 0.1% sodium azide as preservative. 
8. Substrate – Contains Tetramethylbenzidine and hydrogen peroxide. 
9. Wash buffer – contains surfactants. 
10. Stop solution – Diluted sulphuric acid (0.3N). 
11. Microwell holder. 
Reagent preparation: 
i. Wash buffer diluted 20 times with distilled water. 
ii. Antibody reagent diluted 50 times with sample diluents. 
iii. Enzyme conjugate diluted 50 times with conjugate diluent. 
DNA Extraction Kit Components 
Reagents 
1. Proteinase K, lyophilized: One vial with 25 mg of lyophilized 
proteinase K is included. It has to be dissolved in 1.25 ml of 
nuclease-free water and Stored at -200C. 
2. Tissue Lysis buffer  
 3. Binding buffer. 
4. Washing buffer 1 (W1) is supplied in a concentrated form. Before 
the first use, 30 ml of absolute ethanol to be added and 
reconstituted. 
5. Washing buffer 2 (W2) is supplied in a concentrated form. Before     
the first use, it should be reconstituted with 80 ml of absolute  
ethanol.  
6. Elution buffer (EL): 10 mM Tris-Cl (pH 8.5).  
Columns and tubes 
Binding column tubes: 2 ml tubes (for filtration)  
1.5 ml tubes (for elution)  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
PCR kit components 
Color Code Contents 
R1 
Blue MALARIA Super mix. 
R2 
Yellow Mg Sol RT. 
MALARIA-S1 
Red 
MALARIA Standard 1 
1 X 10
5 
copies/µl 
MALARIA-S2 
Red 
MALARIA Standard 2 
1 X 10
4 
copies/µl 
MALARIA-S3 
Red 
MALARIA Standard 3 
1 X 10
3 
copies/µl 
MALARIA-S4 
Red 
MALARIA Standard 4 
1 X 10
2 
copies/µl 
MALARIA-S5 
Red 
MALARIA Standard 5 
1 X 10
1 
copies/µl 
W 
White Molecular Grade Water 
IC-1 (R3) 
Green IC-1 RG (R3) 
R = Reagents  
S = Quantitation Standards 
W = Molecular Grade Water 
  
 (vi) PROFOMA 
 
 
ID No.          :                                       Date:    
  
Patient details: 
Name  :                                                    Address: 
IP/OP No. :                                                                  
Age  :        
Sex  :                                                Occupation:                    
 
Current Symptoms: 
Duration of present illness:                                 
Fever              :                                                              
Chills              :                
Sweating             :            
Headache             :  
Others                                : 
H/O Blood transfusion    :     
H/O Travel to malaria       
 endemic area                   :  
 
Past H/O malaria            : 
Treatment (in the past and the type of Medicines taken):           
Chloroquine               : 
Sulfadoxine/Pyrimethamine : 
Primaquine              :             
Others(Quinolones)  :       
Investigations: 
Peripheral smear (thick and thin smear) 
ICT 
ELISA 
PCR 
  
 
(vii) WORK SHEET 
 
Sample - whole blood                                                                        
(Collect venous blood in an EDTA containing vacutainer). 
 
 Aliquot the blood sample for ELISA and PCR. 
 
Separate the plasma from EDTA added whole blood for PCR  
 
Prepare   peripheral smear with whole blood, stain with Leishman’s stain 
and examine the smear under microscope. 
 
 Immunochromatography test (whole blood). 
 
Perform ELISA for pan malarial pLDH antigen detection                              
[within 24 hours of collection of blood (whole blood)]. 
 
 Perform RT-PCR for detection of Malarial DNA using plasma.  
(On selected samples only) 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 ID.No. Op/IP.No. Name Age/Sex Fever 
with 
chills 
H/O 
BT 
Anti-
malarials 
& 
quinolone 
treatment 
H/O 
Travel  
complic-
ations 
PS ICT ELISA PCR 
1 51915 Ramesh 34/M        +         -    -       +          - Positive(schizonts) for P.v C &T2       +      +   
2   Suresh 54/M        +         -    -       -       - Positive(ring stage & schizonts)for P.v C &T2      +      +   
3   Nithya 27/F        +         -    -       -       - Negative        -  - ND 
4 50171 Pooja 2/FCh        +         -    -       -       - Negative        -   - ND 
5 52604 Vasu 41/M        +         -    -       +          - Negative        -   -   - 
6 53599 Pradeep 10/MCh        +         -    -       -       - Negative        -   -   - 
7 53506 Bijay 19/M        +         -    -       +          - Positive(schizonts) for P.v C &T2      +      +   
8 53237 Boomadevi 50/F        +         -    -       -       - Negative        -  - ND 
9 53036 Murugan 20/M        +         -    -       -       - Negative        -   - ND 
10 53732 Erman 35/M        +         -    -       +           +    Positive(schizonts) for P.v C,T1&T2      +      +   
11 50353 Srikmar 38/M        +         -    -       -       - Negative        -    - ND 
12 53135 Murugan 25/M        +         -    -       -       - Negative        -    - ND 
13 356782 Karthikeyan 25/M        +         -    -       -       - Negative        -    - ND 
14 34522 Anandkumar 4/MCh        +         -    -       -       - Negative        -    - ND 
15 54461 Chadru 10/MCh        +         -    -       +           +    Positive(schizonts) for P.v C,T1&T2      +      +   
16 54021 Chelladurai 40/M        +         -    -       -       - Negative        -    - ND 
 17 54298 Chinnathai 55/M        +         -    -       -       - Negative        -    - ND 
18 54203 Ravikumar 30/M        +         -    -       -       - Negative        -    - ND 
19 50225 Elisa 35/F        +         -    -       -       - Negative        -    - ND 
20 54055 Selvam 45/M        +         -    -       -       - Negative        -    - ND 
21 53732 Erman 35/M        +         -    -       -       - Negative  C&T1    - ND 
22 54100 Arumugam 28/M        +         -    -       -       - Negative        -    - ND 
23   Sundar  25/M        +         -    -       -       - Positive(ring stage & schizonts) for P.v C &T2      +    ND 
24   Lipika 2 1/2/FCh        +         -    -       -       - Negative        -    - ND 
25   Boomika 4/FCh        +         -    -       -       - Negative        -    - ND 
26   Pappan 25/M        +         -    -       -       - Positive(schizonts) for P.v C &T2      +      +   
27 56047 Dharshan priya 4/FCh        +         -    -       -       - Negative        -    - ND 
28 56025 Nagalakshmi 37/F        +         -    -       -       - Negative        -    - ND 
29   Angamuthu 2/MCh        +         -    -       -       - Negative        -    - ND 
30 57933 Mariammal 6/FCh        +         -    -       -       - Negative        -    - ND 
31 57439 Vijay 12/MCh        +         -    -       -       - Negative        -    - ND 
32 57447 Poornachandrika 12/FCh        +         -    -       -       - Negative        -    - ND 
33 58251 Megala 21/2/FCh        +         -    -       -       - Negative        -    -   - 
34 58317 Shravanthi 4/FCh        +         -    -       +          - Positive(schizonts) for P.v C,T1&T2      +      +   
35 58156 Selvam 3/MCh        +         -    -       -       - Negative        -    -   - 
 36 379761 Ajam 22/M        +         -    -       +          - Positive(schizonts) for P.v C &T2      +      +   
37 54684 Chinnasamy 55/M        +         -            +          -       - Negative        -    -   - 
38   Kannan 35/M        +         -    -       -       - Negative        -    - ND 
39   Ganesan 48/M        +         -    -       -       - Positive (gametocyte stage) for P.f C,T1&T2     +      +   
40 54461 Chandru 10/MCh        +         -    -       +          +    Negative  C &T1    - ND 
41 58870 Valarmathy 20/F        +         -    -       -       - Negative        -    - ND 
42 58380 Sathyam 55/M        +         -    -       -       - Negative        -    - ND 
43 59392 Reshma 5/FCh        +         -    -       -       - Negative        -    - ND 
44   Buvaneshpandi 18/F        +         -    -       -       - Negative        -    - ND 
45   Lakhi 30/F        +         -    -       -       - Positive(schizonts) for P.v C &T2     +      +   
46 58920 Rifana 12/FCh        +         -    -       -       - Negative        -    - ND 
47 59507 Haridharni 14/FCh        +         -    -       -       - Negative        -    - ND 
48 59607 Raju 37/M        +         -    -       -       - Negative        -    - ND 
49 59400 Pandiyan 33/M        +         -    -  +         - Positive(ring stage & schizonts) for P.v C &T2      +      +   
50 54321 Thangaraj 12/MCh        +         -    -       -       - Negative        -    - ND 
51 59540 Suganya 12/FCh        +         -    -       -       - Negative        -    - ND 
52 58810 Bavani 5/FCh        +         -    -       -       - Negative        -    - ND 
53   David 53/M        +         -    -       -       - Negative        -    - ND 
54 57931 Mariammal  3/FCh        +         -    -       -       - Negative        -    - ND 
 55   Harish 21/2MCh        +         -    -       -       - Negative        -    - ND 
56 59550 Aruldevan 9/MCh        +         -    -       -       - Negative        -    - ND 
57 59047 Siranjeevi 12/MCh        +         -    -       -       - Negative        -    - ND 
58 60105 Akhim 40/M        +         -    -       -       - Negative        -    - ND 
59   Shakthi 26/F        +         -    -       -       - Negative        -    - ND 
60 60669 Mohammad Ali 39/M        +         -    -       -       - Positive(ring stage & schizonts) for P.v C &T2     +      +   
61 61624 Akshai 13/MCh        +         -    -       -       - Negative        -    - ND 
62 61872 Ajithkumar 36/M        +         -    -       -       - Negative        -    - ND 
63 64499 Kalaiarasu 8/MCh        +         -    -       -       - Negative        -    -   - 
64   Shanthi 38/F        +         -    -       -       - Negative        -    -   - 
65   Ramrav 65/M        +         -    -       -       - Negative        -    -   - 
66 54461 Chandru 10/MCh        +         -    -       +           +    Positive(schizonts) for P.v C &T2      +      +   
67 61922 Rajamani 42/M        +         -    -       -       - Negative        -    -   +   
68 62002 Semaran 30/M        +         -    -       -       - Negative        -    -   +   
69 63052 Poojalakshmi 3/FCh        +         -    -       -       - Negative        -    - ND 
70 62920 Poongodi 5/FCh        +         -    -       -       - Negative        -    - ND 
71 63362 Gopalakrishnan 4/MCh        +         -    -       -       - Negative        -    - ND 
72 61554 Karthikeyan 40/M        +         -    -       -       - Negative        -    - ND 
73 64869 Nithish 4/MCh        +         -    -       -       - Negative        -    -   - 
 74 64957 Padmavathy 26/F        +         -    -       -       - Negative        -    -   +   
75 65113 Ejas 5/MCh        +         -    -       -       - Negative        -    -   - 
76 644376 Meenakshi 35/F        +         -    -       -       - Negative        -    -   - 
77 64250 Rajamani 34/M        +         -    -       -       - Negative        -    -   - 
78 64145 Murugesan 35/M        +         -    -       -       - Negative        -    -   - 
79   Balaji 30/M        +         -    -       -       - Positive (gametocyte stage) for P.f C,T1&T2     +      +   
80 66646 Thanubhadra 25/M        +         -            +          +          - Negative        -     +      +   
81 66566 Karthiga 1/FCh        +         -    -       -       - Negative        -    -   - 
82 66112 Sanjay 7/MCh        +         -    -       -       - Negative        -    -   - 
83 66433 Janaki Eswari 10/FCh        +         -    -       -       - Negative        -    -   - 
84 66111 Shakthivel 4/MCh        +         -    -       -       - Negative        -    - ND 
85 65798 Jayalalitha 27/F        +         -    -       -       - Negative        -    - ND 
86 66680 Karuppannan 18/M        +         -    -       -       - Positive(schizonts) for P.v C &T2      +      +   
87 66780 Savithri 50/F        +         -    -       -       - Negative        -    - ND 
88 66908 Anandkumar 30/M        +         -    -       -       - Negative        -    - ND 
89 67007 Sathish Babu 18/M        +         -    -       -       - Positive(schizonts) for P.v C &T2     +      +   
90 444501 Samira 8/FCh        +         -    -       -       - Negative        -    - ND 
91 439288 Roshan 8/MCh        +         -    -       -       - Negative        -    - ND 
92 437804 Sakila 10/FCh        +         -    -       -       - Negative        -    - ND 
 93 68733 Mubasina 12/FCh        +         -    -       -       - Positive(schizonts) for P.v C &T2     +      +   
94 70972 Srilatha 30/F        +         -    -       -       - Negative        -    - ND 
95 70948 Nandini 28/F        +         -    -       -       - Negative        -    - ND 
96 71037 Mani 32/F        +         -    -       -       - Negative        -    - ND 
97 70756 Linchy  30/F        +         -    -       -       - Negative        -    - ND 
98 45542 Sathyamohan 40/M        +         -    -       -       - Negative        -    - ND 
99 71518 Manikandan 10/MCh        +         -    -       -       - Negative        -    - ND 
100 71129 Ramya 6/FCh        +         -    -    -       - Negative        -    - ND 
101 71958 Arulmani 5/MCh        +         -    -    -       - Negative        -    - ND 
102 71806 Hiran 25/M        +         -    -    -        +    Positive(schizonts) for P.v C,T1&T2    +      +   
103 68247 Ashwini 4/MCh        +         -    -    -       - Negative        -    - ND 
104 480668 Karthikeyan 8/MCh        +         -    -    -       - Negative        -    - ND 
105 481138 Monisha 9/FCh        +         -    -    -       - Negative        -    - ND 
106 71737 Sandhiya 8/FCh        +         -    -    -       - Positive(schizonts) for P.v C &T2    +      +   
107 72671 Sandhya 6/FCh        +         -    -    -       - Negative        -    - ND 
108 71927 Keerthiga 5/FCh        +         -    -    -       - Negative        -    - ND 
109 72354 Masilamani 26/F        +         -    -    -       - Negative        -    - ND 
110 73073 Prakash 9/MCh        +         -    -       -       - Negative        -    - ND 
111 73466 Nithya 5/FCh        +         -    -    -       - Negative        -    - ND 
 112 73848 Umera 7/FCh        +         -    -    -       - Negative        -    - ND 
113 72815 Karyammal 60/F        +         -    -    -       - Positive(schizonts) for P.v C &T2    +      +   
114 1016 Harjith 61/2/Fch        +         -    -    -       - Negative        -    - ND 
115 652 Chandru 24/M        +         -    -    -       - Negative        -    - ND 
116 911 Abhas Ali 30/M        +         -    -    -       - Negative        -    - ND 
117 548 Ajith 3/MCh        +         -    -    -       - Negative        -    - ND 
118 805 Vaishnavi 7/FCh        +         -    -    -       - Negative        -    - ND 
119 4016 Kumutha 4/FCh        +         -    -    -       - Negative        -    - ND 
120 4279 Ishwarya 21/2/FCh        +         -    -    -       - Negative        -    - ND 
121 4212 Sweetha 3/FCh        +         -    -    -       - Negative        -    - ND 
122 4142 Kumari 37/F        +         -    -    -       - Negative        -    - ND 
123 7958 Anbarasu 4/MCh        +         -    -    -       - Negative        -    - ND 
124 7973 Aravind 6/Mch        +         -    -    -       - Negative        -    - ND 
125 8007 Preethi 21/F        +         -    -    -       - Negative        -    - ND 
126 8092 Karthika 8/FCh        +         -    -    -       - Negative        -    - ND 
127 7862 Kaligaraj 32/M        +         -    -    -       - Negative        -    - ND 
128 8686 Siva 29/M        +         -    -    -       - Negative        -    - ND 
129 8571 Rabiya 27/F        +         -    -    -       - Negative        -    - ND 
130 8858 Sikkanthar 35/M        +         -    -    -       - Negative        -    - ND 
 131 14277 Mohammad 4/MCh        +         -    -    -       - Negative        -    - ND 
132 14908 Lalith chandran 3/MCh        +         -    -    -       - Negative        -    - ND 
133 15559 Sriram 6/Mch        +         -    -    -       - Negative        -    - ND 
134 15893 Md Sameem 8/MCh        +         -    -    -       - Negative        -    - ND 
135 13197 Buvaneshwari 28/F        +         -    -    -       - Negative        -    - ND 
136 12836 Nagal 35/F        +         -    -    -       - Negative        -    - ND 
137 12910 Jeganathan 25/M        +         -    -    -       - Negative        -    - ND 
138 13112 Habibul 19/M        +         -    -    -       - Negative        -    - ND 
139 19868 Veni 26/F        +         -    -    -       - Negative        -    - ND 
140 19555 Priya 40/F        +         -    -    -       - Negative        -    - ND 
141 19838 Boopathi 6/Mch        +         -    -    -       - Negative        -    - ND 
142 20234 Subban 54/M        +         -    -    -       - Negative        -    - ND 
143 20168 Mahali 44/M        +         -    -    -       - Negative        -    - ND 
144 26535 Thulasiammal 40/F        +         -    -    -       - Negative        -    - ND 
145 202075 Kanimozhi 38/F        +         -    -    -       - Negative        -    - ND 
146 26031 Surya 25/F        +         -    -    -       - Negative        -    - ND 
147 26862 Deva 35/M        +         -    -    -       - Positive(ring stage with schuffner dots) 
for P.v 
C &T2    +    ND 
148 28818 Dhakshanamoorthy 50/M        +         -    -    -       - Negative        -    - ND 
149 28869 Santhoshkumar 40/M        +         -    -    -       - Negative        -    - ND 
 150 28152 Bakyalakshmi 35/F        +         -    -    -       - Negative        -    - ND 
151 30176 Ramkishore 32/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
152 30076 Velu 40/M        +         -    -    -       - Negative        -    - ND 
153 30280 Manoj 35/M        +         -    -    -       - Negative        -    - ND 
154 30246 Sayed Ahmed 46/M        +         -    -    -       - Negative        -    - ND 
155 30063 Thulasimani 23/F        +         -    -    -       - Negative        -    - ND 
156 24640 Gokul 10/MCh        +         -    -    -       - Negative        -    - ND 
157 31241 Seenu 16/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
158 31253 Kittan 71/M        +         -    -    -       - Negative        -    - ND 
159 31186 Arumugam 46/M        +         -    -    -       - Negative        -    - ND 
160 31091 Dharshan 1/MCh        +         -    -    -       - Negative        -    - ND 
161 31647 Venkatachalam 35/M        +         -    -    -       - Negative        -    - ND 
162 31645 Varun 11/MCh        +         -    -    -       - Positive(ring stage & schizonts) for P.v C &T2    +    ND 
163 31888 Papammal 52/F        +         -    -    -       - Negative        -    - ND 
164 35963 Esthar 37/F        +         -    -    -       - Negative        -    - ND 
165 35820 Rajammal 51/F        +         -    -    -       - Negative        -    - ND 
166 34233 Amudha 1/FCh        +         -    -    -       - Negative        -    - ND 
167 36568 Aarish 1/MCh        +         -    -    -       - Positive(ring stage) for P.v C &T2    +    ND 
 168 36870 Suhavil 6/MCh        +         -    -    -       - Negative        -    - ND 
169 37926 Thulasimani 2/FCh        +         -    -    -       - Negative        -    - ND 
170 37139 Laila 40/F        +         -    -    -       - Negative        -    - ND 
171 37139 Shanthamani 33/F        +         -    -    -       - Negative        -    - ND 
172 38124 Vivekanandan 49/M        +         -    -    -       - Negative        -    - ND 
173 37712 Praveena 28/F        +         -    -    -       - Negative        -    - ND 
174 38192 Muthusamy 53/M        +         -    -    -       - Negative        -    - ND 
175 38323 Amitkumar 27/M        +         -    -    -       - Positive(ring stage with schuffner dots) 
for P.v 
C &T2    +    ND 
176 43546 Divya 3/FCh        +         -    -    -        +    Positive for  ring stage of P.v & 
gametocyte of P.f 
C,T1&T2    +    ND 
177 43632 Rangasamy 90/M        +         -    -    -       - Negative        -    - ND 
178 41170 Saradamani 52/F        +         -    -    -       - Negative        -    - ND 
179 43635 Poornima 6/FCh        +         -    -    -       - Negative        -    - ND 
180 42926 Vadivel 35/M        +         -    -    -       - Negative        -    - ND 
181 44082 Vijaya 50/F        +         -    -    -       - Negative        -    - ND 
182 43677 Sundharam 21/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
183 44047 Prabakaran 20/M        +         -    -    -       - Negative        -    - ND 
184 44020 Karthi 11/MCh        +         -    -    -       - Negative        -    - ND 
185 44349 Balamohan 35/M        +         -    -    -       - Negative        -    - ND 
 186 44021 Karthikeyan 9/MCh        +         -    -    -       - Negative        -    - ND 
187 46412 Selvaraj 15/M        +         -    -    -       - Negative        -    - ND 
188 338428 Nithish 11/2/MCh        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
189 46381 Deepak kumar 30/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
190 46384 Marappan 35/M        +         -    -    -       - Negative        -    - ND 
191 46673 Karthikeyan 75/M        +         -    -    -       - Negative        -    - ND 
192 46675 Rathamani 48/F        +         -    -    -       - Negative        -    - ND 
193 46966 Chinnasamy 40/M        +         -    -    -       - Negative        -    - ND 
194 47019 Srirashavan 1/MCh        +         -    -    -       - Negative        -    - ND 
195 46966 Chinnasamy 40/M        +         -    -    -       - Negative        -    - ND 
196 46851 Peter 35/M        +         -    -    -       - Negative        -    - ND 
197 49213 Chinnasamy 30/M        +         -    -    -       - Negative        -    - ND 
198 49330 Mariammal 45/M        +         -    -    -       - Negative        -    - ND 
199 49624 Kamalesh 6/MCh        +         -    -    -       - Negative        -    - ND 
200 49870 Vellayangiri 17/M        +         -    -    -       - Negative        -    - ND 
201 50011 Boopathy  32/M        +         -    -    -       - Positive(ring stage & schizonts) for P.v C &T2    +    ND 
202 50150 Sureshkumar 48/M        +         -    -    -       - Positive(ring stage & schizonts) for P.v C &T2    +    ND 
203 50070 Hari 21/M        +         -    -    -       - Negative        -    - ND 
 204 49958 Safiya parveen 6/FCh        +         -    -    -       - Negative        -    - ND 
205 50139 Bathruvin 29/M        +         -    -    -       - Negative        -    - ND 
206 50178 Kasthuri 26/F        +         -    -    -       - Negative        -    - ND 
207 49821 Rohit kumar 25/M        +         -    -       +          - Positive(ring stage & schizonts) for P.v C,T1&T2    +    ND 
208 47334 Manjuladevi 23/F        +         -    -    -       - Negative        -    - ND 
209 47415 Sathyapriyanka 19/F        +         -    -    -       - Negative        -    - ND 
210 49099 Asrafi pradad 46/M        +         -    -    -       - Negative        -    - ND 
211 50346 Radha 60/F        +         -    -    -       - Negative        -    - ND 
212 51195 Babulu 23/M        +         -    -       +          - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
213 50780 Berendrakumar 26/M        +         -    -    -       - Negative        -    - ND 
214 51444 Omm 6/MCh        +         -    -    -       - Positive (trophozoites stage) for P.v C &T2    +    ND 
215 51521 Siyaram 22/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
216 50278 Maheswari 27/F        +         -    -    -       - Negative        -    - ND 
217 51684 Vishnupriya 30/F        +         -    -    -       - Negative        -    - ND 
218 57878 Ganesh 11/2/MCh        +         -    -    -       - Negative        -    - ND 
219 51606 Patchiyammal 55/F        +         -    -    -       - Negative        -    - ND 
220 52500 Rajarajeswaran 23/M        +         -    -    -       - Negative        -    - ND 
221 51731 Nagammal 45/F        +         -    -    -       - Negative        -    - ND 
 222 52069 Devadhe 51/M        +         -    -       +          - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
223 52194 Chellammal 57/F        +         -    -    -       - Negative        -    - ND 
224 52116 Pramod Radhan 23/M        +         -    -    -       - Negative        -    - ND 
225 52118 Marathal 25/F        +         -    -    -       - Negative        -    - ND 
226 52337 Kumar 20/M        +         -    -    -       - Negative        -    - ND 
227 52391 Ajaykumar 12/MCh        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
228 53225 Iyyappan 37/M        +         -    -    -       - Negative        -    - ND 
229 53073 Balraj 33/M        +         -    -    -       - Negative        -    - ND 
230 53287 Subramani 37/M        +         -    -    -       - Negative        -    - ND 
231 53448 Chinnasamy 53/M        +         -    -    -       - Negative        -    - ND 
232 53523 Gowri 22/F        +         -    -    -       - Negative        -    - ND 
233 53608 Babukumar 24/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
234 53608 Ambi 37/M        +         -    -    -       - Negative        -    - ND 
235 53544 Mahalakshmi 31/F        +         -    -    -       - Negative        -    - ND 
236 53647 Maran 30/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
237 53547 Manikandan 24/M        +         -    -    -       - Negative        -    - ND 
238 53668 Krishnamoorthy 35/M        +         -    -    -       - Negative        -    - ND 
 239 53893 Sasikumar 28/M        +         -    -    -       - Negative        -    - ND 
240 53850 Ravindrakumar 21/M        +         -    -    -       - Positive (ring stage, trophozoites with 
schuffner dots) for P.v 
C &T2    +    ND 
241 53900 Ashwin 11/2/MCh        +         -    -    -       - Negative        -    - ND 
242 53930 Nihal 3/FCh        +         -    -    -       - Negative        -    - ND 
 (ix) KEY TO MASTER CHART 
Sex: 
 M – Male 
 F – Female  
BT – Blood Transfusion 
PS – Peripheral smear 
 P.v – Plasmodium vivax  
 P.f – Plasmodium falciparum 
ICT – Immunochromatography test 
 C- Control line 
 T1 – Test line 1 
 T2 – Test line 2 
ELISA – Enzyme Linked Immunosorbent Assay 
PCR – Polymerase Chain Reaction 
   ND – Test not done.  
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data obtained herein may be used for research and publication. I whole 
heartedly give my consent to participate in the study.  
Place: 
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A Review of Alternatives to Conventional Microscopy in the 
Laboratory Diagnosis of Malaria 
ABSTRACT: 
Background: Malaria is the disease of antiquity, having been recognized since Vedic times in 
India 1,2. It is distributed worldwide with a great socioeconomic impact on the countries with 
intense transmission particularly in tropical regions 3. Patients affected with malaria present with 
varied clinical picture from fever and malaise to life threatening symptoms like cerebral malaria. 
Diagnosing malaria based on clinical features alone may lead to over-diagnosis especially in 
endemic areas. Thus parasite based diagnosis is recommended for all patients by WHO. This 
study is focused on alternatives to conventional microscopy in the laboratory diagnosis of 
malaria.  
Objectives:  1.To identify malarial parasite in patients with low parasite densities. 2. To 
compare the sensitivity and specificity of Rapid Diagnostic    Test (RDT) with conventional 
microscopy. 3. To evaluate the diagnostic performance of pLDH Antigen detection ELISA. 4. To 
evaluate the role of PCR in the diagnosis of malaria.  
Materials and Methods: This is a cross-sectional study conducted over a period of one year 
from September 2011 to September 2012. The study group included patients of all age groups 
and both sexes who were clinically suspected to have malarial fever (both inpatients and 
outpatients). Blood samples from these 242 patients were collected in a vacutainer with EDTA 
anticoagulant. Leishman’s staining of the Peripheral smear, Rapid diagnostic test and ELISA for 
parasite specific pan malarial antigen (LDH) detection were done on all the samples. PCR was 
done with plasma for a total of 40 samples (20 microscopy positive and 20 microscopy negative 
samples). 
 Results: Peripheral smear was considered as the Gold standard test. ICT, ELISA and PCR were 
compared with the Gold Standard peripheral blood smear. Microscopy detected 42 cases 
(17.4%), ICT was able to detect 44 cases (18.8%) and ELISA detected 43 cases (17.8%). ICT 
detected mixed infection of Plasmodium falciparum with other Plasmodium species in 6 cases 
whereas microscopy detected only one mixed infection. RT-PCR detected 4 cases as positive for 
malaria among the 20 microscopy negative samples. All the three recent diagnostic methods 
(ICT, ELISA and PCR) were found to be 100% sensitive when compared to microscopy in the 
diagnosis of malaria.  
Conclusion:  Of the diagnostic methods studied, non-microscopic method like ICT is a good 
adjunct to microscopy in diagnosis of malaria, ICT and ELISA are good alternatives to 
microscopy in blood banks and RT-PCR is the best method in diagnosis of malaria especially in 
cases of Pyrexia of Unknown Origin with low parasitemia i.e., below the detection limit of 
peripheral smear. 
Keywords: Malaria, ICT, ELISA, RT-PCR. 
